Honeywell International (HON) 10-Q 29 Apr 22 2022 Q1 Quarterly report Financial data

Cover Page

Cover Page	3 Months Ended
	Mar. 31, 2022shares
Entity Listings [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document period end date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	1-8974
Entity registrant name	Honeywell International Inc
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	22-2640650
Entity Address, Address Line One	855 South Mint Street
Entity Address, City or Town	Charlotte,
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	28202
City Area Code	(704)
Local Phone Number	627-6200
Entity current reporting status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	680,732,930
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Central Index Key	0000773840
Current Fiscal Year End Date	--12-31
Common stock, par value
Entity Listings [Line Items]
Title of each class	Common Stock, par value $1 per share*
Trading Symbol(s)	HON
Name of each exchange on which registered	NASDAQ
1.300% Senior Notes due 2023
Entity Listings [Line Items]
Title of each class	1.300% Senior Notes due 2023
Trading Symbol(s)	HON 23A
Name of each exchange on which registered	NASDAQ
0.000% Senior Notes due 2024
Entity Listings [Line Items]
Title of each class	0.000% Senior Notes due 2024
Trading Symbol(s)	HON 24A
Name of each exchange on which registered	NASDAQ
2.250% Senior Notes due 2028
Entity Listings [Line Items]
Title of each class	2.250% Senior Notes due 2028
Trading Symbol(s)	HON 28A
Name of each exchange on which registered	NASDAQ
0.750% Senior Notes due 2032
Entity Listings [Line Items]
Title of each class	0.750% Senior Notes due 2032
Trading Symbol(s)	HON 32
Name of each exchange on which registered	NASDAQ

CONSOLIDATED STATEMENT OF OPERA

CONSOLIDATED STATEMENT OF OPERATIONS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Net sales	$ 8,376	$ 8,454
Costs, expenses and other
Costs	5,674	5,709
Selling, general and administrative expenses	1,431	1,236
Other (income) expense	(319)	(442)
Interest and other financial charges	85	90
Costs, expenses and other	6,871	6,593
Income before taxes	1,505	1,861
Tax expense	371	413
Net income	1,134	1,448
Less: Net income attributable to the noncontrolling interest	0	21
Net income attributable to Honeywell	$ 1,134	$ 1,427
Earnings per share of common stock - basic (in dollars per share)	$ 1.66	$ 2.05
Earnings per share of common stock - assuming dilution (in dollars per share)	$ 1.64	$ 2.03
Product
Net sales	$ 6,132	$ 6,409
Costs, expenses and other
Costs	4,373	4,551
Service
Net sales	2,244	2,045
Costs, expenses and other
Costs	$ 1,301	$ 1,158

CONSOLIDATED STATEMENT OF COMPR

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 1,134	$ 1,448
Other comprehensive income (loss), net of tax
Foreign exchange translation adjustment	126	214
Prior service (credit) cost recognized	(17)	(22)
Pension and other postretirement benefit adjustments	(17)	(22)
Changes in fair value of available for sale investments	(6)	(3)
Cash flow hedges recognized in other comprehensive income (loss)	8	8
Less: Reclassification adjustment for gains (losses) included in net income	3	3
Changes in fair value of cash flow hedges	5	5
Other comprehensive income (loss), net of tax	108	194
Comprehensive income	1,242	1,642
Less: Comprehensive income attributable to the noncontrolling interest	0	22
Comprehensive income attributable to Honeywell	$ 1,242	$ 1,620

CONSOLIDATED BALANCE SHEET

CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 9,281	$ 10,959
Short-term investments	493	564
Accounts receivable, less allowances of $326 and $177, respectively	7,119	6,830
Inventories	5,472	5,138
Other current assets	1,916	1,881
Total current assets	24,281	25,372
Investments and long-term receivables	1,035	1,222
Property, plant and equipment - net	5,470	5,562
Goodwill	17,863	17,756
Other intangible assets - net	3,534	3,613
Insurance recoveries for asbestos related liabilities	314	322
Deferred income taxes	494	489
Other assets	10,361	10,134
Total assets	63,352	64,470
Current liabilities:
Accounts payable	6,285	6,484
Commercial paper and other short-term borrowings	3,526	3,542
Current maturities of long-term debt	3,207	1,803
Accrued liabilities	7,009	7,679
Total current liabilities	20,027	19,508
Long-term debt	12,636	14,254
Deferred income taxes	2,387	2,364
Postretirement benefit obligations other than pensions	220	208
Asbestos-related liabilities	1,807	1,800
Other liabilities	7,217	7,087
Redeemable noncontrolling interest	7	7
SHAREOWNERS’ EQUITY
Capital - common stock issued	958	958
Capital - additional paid in capital	8,326	8,141
Common stock held in treasury, at cost	(31,420)	(30,462)
Accumulated other comprehensive loss	(2,787)	(2,895)
Retained earnings	43,288	42,827
Total Honeywell shareowners’ equity	18,365	18,569
Noncontrolling interest	686	673
Total shareowners’ equity	19,051	19,242
Total liabilities, redeemable noncontrolling interest and shareowners’ equity	$ 63,352	$ 64,470

CONSOLIDATED BALANCE SHEET (Par

CONSOLIDATED BALANCE SHEET (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ 326	$ 177

CONSOLIDATED STATEMENT OF CASH

CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income	$ 1,134	$ 1,448
Less: Net income attributable to the noncontrolling interest	0	21
Net income attributable to Honeywell	1,134	1,427
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities:
Depreciation	167	171
Amortization	163	170
Gain on sale of non-strategic businesses and assets	0	(90)
Repositioning and other charges	387	141
Net payments for repositioning and other charges	(108)	(195)
Pension and other postretirement income	(261)	(293)
Pension and other postretirement benefit payments	(14)	(14)
Stock compensation expense	60	77
Deferred income taxes	21	63
Other	(67)	(96)
Changes in assets and liabilities, net of the effects of acquisitions and divestitures:
Accounts receivable	(285)	143
Inventories	(331)	(158)
Other current assets	(29)	(66)
Accounts payable	(199)	57
Accrued liabilities	(602)	(359)
Net cash provided by operating activities	36	978
Cash flows from investing activities:
Expenditures for property, plant and equipment	(183)	(221)
Proceeds from disposals of property, plant and equipment	10	14
Increase in investments	(223)	(736)
Decrease in investments	304	612
Receipts from Garrett Motion Inc.	197	0
Receipts (payments) from settlements of derivative contracts	61	140
Cash paid for acquisitions, net of cash acquired	(176)	(1,303)
Proceeds from sales of businesses, net of fees paid	0	190
Net cash used for investing activities	(10)	(1,304)
Cash flows from financing activities:
Proceeds from issuance of commercial paper and other short-term borrowings	1,228	1,268
Payments of commercial paper and other short-term borrowings	(1,228)	(1,266)
Proceeds from issuance of common stock	23	67
Proceeds from issuance of long-term debt	1	23
Payments of long-term debt	(40)	(817)
Repurchases of common stock	(1,018)	(822)
Cash dividends paid	(668)	(640)
Other	(17)	(30)
Net cash used for financing activities	(1,719)	(2,217)
Effect of foreign exchange rate changes on cash and cash equivalents	15	(14)
Net increase (decrease) in cash and cash equivalents	(1,678)	(2,557)
Cash and cash equivalents at beginning of period	10,959	14,275
Cash and cash equivalents at end of period	$ 9,281	$ 11,718

CONSOLIDATED STATEMENT OF SHARE

CONSOLIDATED STATEMENT OF SHAREOWNERS' EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common stock, par value	Additional paid-in capital	Treasury stock	Retained earnings	Accumulated other comprehensive income (loss)	Noncontrolling interest
Balance at beginning of period at Dec. 31, 2020			$ 7,292	$ (27,229)	$ 39,905	$ (3,377)	$ 241
Treasury stock, beginning balance (in shares) at Dec. 31, 2020				(260.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reacquired stock or repurchases of common stock (in shares)				(4)
Reacquired stock or repurchases of common stock				$ (822)
Issued for employee savings and option plans (in shares)				1.8
Issued for employee savings and option plans			136	$ 76
Stock-based compensation expense			77
Net income attributable to Honeywell	$ 1,427				1,427
Dividends on common stock					(650)
Net income attributable to noncontrolling interest	21						21
Foreign exchange translation adjustment	214					213	1
Pension and other postretirement benefit adjustments	(22)					(22)
Changes in fair value of available for sale investments						(3)
Changes in fair value of cash flow hedges	5					5
Dividends paid							(1)
Contributions from noncontrolling interest holders							4
Treasury stock, ending balance (in shares) at Mar. 31, 2021				(263)
Balance at end of period at Mar. 31, 2021	$ 18,252	$ 958	7,505	$ (27,975)	40,682	(3,184)	266
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends per share of common stock (in dollars per share)	$ 0.930
Common stock, par value (in shares)	957.6	957.6
Total shareowners' equity (in shares)	694.6
Balance at beginning of period at Dec. 31, 2021	$ 19,242		8,141	$ (30,462)	42,827	(2,895)	673
Treasury stock, beginning balance (in shares) at Dec. 31, 2021				(272.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reacquired stock or repurchases of common stock (in shares)				(5.5)
Reacquired stock or repurchases of common stock				$ (1,018)
Issued for employee savings and option plans (in shares)				1.4
Issued for employee savings and option plans			116	$ 60
Stock-based compensation expense			69
Net income attributable to Honeywell	1,134				1,134
Dividends on common stock					(673)
Net income attributable to noncontrolling interest	0						0
Foreign exchange translation adjustment	126					126	0
Pension and other postretirement benefit adjustments	(17)					(17)
Changes in fair value of available for sale investments						(6)
Changes in fair value of cash flow hedges	5					5
Dividends paid							(1)
Contributions from noncontrolling interest holders							14
Treasury stock, ending balance (in shares) at Mar. 31, 2022				(276.9)
Balance at end of period at Mar. 31, 2022	$ 19,051	$ 958	$ 8,326	$ (31,420)	$ 43,288	$ (2,787)	$ 686
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends per share of common stock (in dollars per share)	$ 0.980
Common stock, par value (in shares)	957.6	957.6
Total shareowners' equity (in shares)	680.7

BASIS OF PRESENTATION

BASIS OF PRESENTATION	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATIONIn the opinion of management, the accompanying unaudited Consolidated Financial Statements reflect all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the financial position, results of operations, cash flows, and shareowners' equity of Honeywell International Inc. and its consolidated subsidiaries (Honeywell or the Company) for the periods presented. The interim results of operations and cash flows should not necessarily be taken as indicative of the entire year.Honeywell reports its quarterly financial information using a calendar convention; the first, second, and third quarters are consistently reported as ending on March 31, June 30, and September 30, respectively. It has been Honeywell's practice to establish actual quarterly closing dates using a predetermined fiscal calendar, which requires Honeywell's businesses to close their books on a Saturday in order to minimize the potentially disruptive effects of quarterly closing on the Company's business processes. The effects of this practice are generally not significant to reported results for any quarter and only exist within a reporting year. In the event differences in actual closing dates are material to year-over-year comparisons of quarterly or year-to-date results, Honeywell will provide appropriate disclosures. Honeywell's actual closing dates for the three months ended March 31, 2022, and March 31, 2021, were April 2, 2022, and April 3, 2021, respectively.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The accounting policies of the Company are set forth in Note 1 to the Company's Consolidated Financial Statements contained in the Company’s 2021 Annual Report on Form 10-K. The Company includes herein certain updates to those policies. RECLASSIFICATIONS Certain prior year amounts have been reclassified to conform to the current year presentation. RECENT ACCOUNTING PRONOUNCEMENTS The Company considers the applicability and impact of all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB). ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company's Consolidated Financial Statements. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by the transition away from reference rates expected to be discontinued to alternative reference rates. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope , to expand the scope of this guidance to include derivatives. The guidance was effective upon issuance and may be applied prospectively to contract modifications made and hedging relationships entered into on or before December 31, 2022. The Company will apply the guidance to impacted transactions during the transition period. The adoption of this standard does not have a material impact on the Company’s Consolidated Financial Statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805) : Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. This ASU should be applied prospectively to acquisitions occurring on or after the effective date of December 15, 2022, and early adoption is permitted. The Company adopted this guidance on January 1, 2022. The adoption of this standard does not have a material impact on the Company’s Consolidated Financial Statements.

ACQUISITIONS AND DIVESTITURES

ACQUISITIONS AND DIVESTITURES	3 Months Ended
	Mar. 31, 2022
Business Combination and Asset Acquisition [Abstract]
ACQUISITIONS AND DIVESTITURES	ACQUISITIONS AND DIVESTITURES ACQUISITIONS On January 18, 2022, the Company acquired 100% of the issued and outstanding shares of US Digital Design, Inc., a leading provider of technologies for first responders, for total consideration of $184 million. The business is included within the Honeywell Building Technologies segment. The assets and liabilities acquired with US Digital Designs, Inc. are included in the Consolidated Balance Sheet as of March 31, 2022, including $47 million of intangible assets and $133 million allocated to goodwill, which is deductible for tax purposes. The purchase accounting is subject to final adjustment, primarily for the valuation of intangible assets, amounts allocated to goodwill, and tax balances. DIVESTITURES During 2022, there were no significant divestitures that closed individually or in the aggregate.

REVENUE RECOGNITION AND CONTRAC

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS	REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS Honeywell generates revenue from a comprehensive offering of products and services, including software and technologies, that are sold to a variety of customers in multiple end markets. See the following table and related discussions by operating segment for details. Three Months Ended March 31, 2022 2021 Aerospace Commercial Aviation Original Equipment $ 478 $ 431 Commercial Aviation Aftermarket 1,168 910 Defense and Space 1,103 1,291 2,749 2,632 Honeywell Building Technologies Products 879 784 Building Solutions 550 574 1,429 1,358 Performance Materials and Technologies UOP 480 527 Process Solutions 1,152 1,096 Advanced Materials 821 723 2,453 2,346 Safety and Productivity Solutions Safety and Retail 511 743 Productivity Solutions and Services 391 346 Warehouse and Workflow Solutions 599 831 Advanced Sensing Technologies 243 198 1,744 2,118 Corporate and All Other 1 — Net sales $ 8,376 $ 8,454 Aerospace – A global supplier of products, software and services for aircrafts that it sells to OEM and other customers in a variety of end markets including: air transport, regional, business and general aviation aircraft, airlines, aircraft operators and defense and space contractors. Aerospace products and services include auxiliary power units, propulsion engines, environmental control systems, integrated avionics, wireless connectivity services, electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, management and technical services, advanced systems and instruments, satellite and space components, aircraft wheels and brakes, repair, and overhaul services and thermal systems. Aerospace also provides spare parts, repair, overhaul and maintenance services (principally to aircraft operators) for the aftermarket. Honeywell Forge solutions are leveraged by the Company's customers as tools to turn data into predictive maintenance and predictive analytics to enable better fleet management and make flight operations more efficient. Honeywell Building Technologies – A global provider of products, software, solutions, and technologies that enable building owners and occupants to ensure their facilities are safe, energy efficient, sustainable, and productive. Honeywell Building Technologies products and services include advanced software applications for building control and optimization; sensors, switches, control systems, and instruments for energy management; access control; video surveillance; fire products; and installation, maintenance and upgrades of systems. Honeywell Forge solutions enable the Company's customers to digitally manage buildings, connecting data from different assets to enable smart maintenance, improve building performance, and even protect from incoming security threats. Performance Materials and Technologies – A global provider in developing and manufacturing high-quality performance chemicals and materials, process technologies, and automation solutions. The segment is comprised of Process Solutions, UOP, and Advanced Materials. Process Solutions provides automation control, instrumentation, advanced software, and related services for the oil and gas, refining, pulp and paper, industrial power generation, chemicals and petrochemicals, biofuels, life sciences, and metals, minerals, and mining industries. Through its smart energy products, Process Solutions enables utilities and distribution companies to deploy advanced capabilities to improve operations, reliability, and environmental sustainability. UOP provides process technology, products, including catalysts and adsorbents, equipment, and consulting services that enable customers to efficiently produce gasoline, diesel, jet fuel, petrochemicals and renewable fuels for the petroleum refining, gas processing, petrochemical, and other industries. Advanced Materials manufactures a wide variety of high-performance products, including materials used to manufacture end products such as bullet-resistant armor, nylon, computer chips, and pharmaceutical packaging, and provides reduced and low global-warming-potential materials based on hydrofluoro-olefin technology. In the industrial environment, Honeywell Forge solutions enable integration and connectivity to provide a holistic view of operations and turn data into clear actions to maximize productivity and efficiency. Honeywell Forge's cybersecurity capabilities help identify risks and act on cyber-related incidents, together enabling improved operations and protecting processes, people and assets. Safety and Productivity Solutions – A global provider of products and software that improve productivity, workplace safety and asset performance to customers around the globe. Safety products include PPE, apparel, gear, and footwear; gas detection technology; and cloud-based notification and emergency messaging. Productivity Solutions products and services include mobile devices and software for computing, data collection, and thermal printing; supply chain and warehouse automation equipment, software and solutions; custom-engineered sensors, switches and controls for sensing and productivity solutions; and software-based data and asset management productivity solutions. Honeywell Forge solutions digitally automate processes to improve efficiency while reducing downtime and safety costs. Corporate and All Other – Corporate and All Other includes revenue from Honeywell's majority-owned investment in Quantinuum. Through Quantinuum, Honeywell provides a wide range of service offerings of fully integrated quantum computing hardware and software solutions. For a summary by disaggregated product and services sales for each segment, refer to Note 17 Segment Financial Data. The Company recognizes revenue from performance obligations to customers that are satisfied at a point in time and over time. The disaggregation of the Company's revenue based off timing of recognition is as follows: Three Months Ended March 31, 2022 2021 Products, transferred point in time 59 % 58 % Products, transferred over time 14 18 Net product sales 73 76 Services, transferred point in time 8 7 Services, transferred over time 19 17 Net service sales 27 24 Net sales 100 % 100 % CONTRACT BALANCES The Company records progress on satisfying performance obligations to customers, and the related billings and cash collections, on the Consolidated Balance Sheet in Accounts receivable - net and Other assets (unbilled receivables (contract assets) and billed receivables) and Accrued liabilities and Other liabilities (customer advances and deposits (contract liabilities)). Unbilled receivables (contract assets) arise when the timing of cash collected from customers differs from the timing of revenue recognition, such as when contract provisions require specific milestones to be met before a customer can be billed. Unbilled receivable balance increases when the revenue associated with the contract is recognized prior to billing and decreases when billed in accordance with the terms of the contract. Contract liabilities increase when customers remit contractual cash payments in advance of the Company satisfying performance obligations under contractual arrangements, including those with performance obligations to be satisfied over a period of time. Contract liabilities decrease when revenue is recorded, either when a milestone is met triggering the contractual right to bill or when the performance obligation is satisfied. Contract balances are classified as assets or liabilities on a contract-by-contract basis at the end of each reporting period. The following table summarizes the Company's contract assets and liabilities balances: 2022 2021 Contract assets - January 1 $ 2,060 $ 1,618 Contract assets - March 31 2,170 1,789 Change in contract assets - increase (decrease) $ 110 $ 171 Contract liabilities - January 1 $ (4,290) $ (4,033) Contract liabilities - March 31 (4,323) (3,994) Change in contract liabilities - decrease (increase) $ (33) $ 39 Net change $ 77 $ 210 For the three months ended March 31, 2022 and 2021, the Company recognized revenue of $927 and $1,120 million that was previously included in the beginning balance of contract liabilities. Contract assets include $2,143 million and $2,035 million of unbilled balances under long-term contracts as of March 31, 2022 and December 31, 2021, respectively. These amounts are billed in accordance with the terms of customer contracts to which they relate. When contracts are modified to account for changes in contract specifications and requirements, the Company considers whether the modification either creates new or changes the existing enforceable rights and obligations. Contract modifications that are for goods or services that are not distinct from the existing contract, due to the significant integration with the original good or service provided, are accounted for as if they were part of that existing contract. The effect of a contract modification on the transaction price, and the Company's measure of progress for the performance obligation to which it relates, is recognized as an adjustment to revenue (either as an increase in or a reduction of revenue) on a cumulative catch-up basis. When the modifications include additional performance obligations that are distinct and at relative stand-alone selling price, they are accounted for as a new contract and performance obligation, which are recognized prospectively. PERFORMANCE OBLIGATIONS A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is defined as the unit of account. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When the Company's contracts with customers require highly complex integration or manufacturing services that are not separately identifiable from other promises in the contracts and, therefore, not distinct, then the entire contract is accounted for as a single performance obligation. In situations when the Company's contract includes distinct goods or services that are substantially the same and have the same pattern of transfer to the customer over time, they are recognized as a series of distinct goods or services. For any contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation based on the estimated relative standalone selling price of each distinct good or service in the contract. For product sales, each product sold to a customer typically represents a distinct performance obligation. In such cases, the observable standalone sales are used to determine the standalone selling price. Performance obligations are satisfied as of a point in time or over time. Performance obligations are supported by contracts with customers, providing a framework for the nature of the distinct goods, services or bundle of goods and services. The timing of satisfying the performance obligation is typically indicated by the terms of the contract. The following table outlines the Company's remaining performance obligations disaggregated by segment: March 31, 2022 Aerospace $ 10,211 Honeywell Building Technologies 7,177 Performance Materials and Technologies 7,245 Safety and Productivity Solutions 3,861 Corporate and All Other (1) 1 Total Performance Obligations $ 28,495 (1) The remaining performance obligations within Corporate and All Other relate to the Quantinuum business. Performance obligations recognized as of March 31, 2022, will be satisfied over the course of future periods. The Company's disclosure of the timing for satisfying the performance obligation is based on the requirements of contracts with customers. However, from time to time, these contracts may be subject to modifications, impacting the timing of satisfying the performance obligations. Performance obligations expected to be satisfied within one year and greater than one year are 59% and 41%, respectively. The timing of satisfaction of the Company's performance obligations does not significantly vary from the typical timing of payment. Typical payment terms of the Company's fixed-price over time contracts include progress payments based on specified events or milestones, or based on project progress. For some contracts the Company may be entitled to receive an advance payment. The Company applied the practical expedient for certain revenue streams to exclude the value of remaining performance obligations for (i) contracts with an original expected term of one year or less or (ii) contracts for which the Company recognizes revenue in proportion to the amount the Company has the right to invoice for services performed.

REPOSITIONING AND OTHER CHARGES

REPOSITIONING AND OTHER CHARGES	3 Months Ended
	Mar. 31, 2022
Restructuring and Related Activities [Abstract]
REPOSITIONING AND OTHER CHARGES	REPOSITIONING AND OTHER CHARGES A summary of repositioning and other charges follows: Three Months Ended March 31, 2022 2021 Severance $ 7 $ 28 Asset impairments 123 42 Exit costs 17 49 Reserve adjustments (15) 1 Total net repositioning charge 132 120 Asbestos related litigation charges, net of insurance and reimbursements 46 21 Probable and reasonably estimable environmental liabilities, net of reimbursements 14 5 Other 195 (5) Total net repositioning and other charges $ 387 $ 141 The following table summarizes the pretax distribution of total net repositioning and other charges by classification: Three Months Ended March 31, 2022 2021 Cost of products and services sold $ 199 $ 98 Selling, general and administrative expenses 188 43 $ 387 $ 141 The following table summarizes the pretax impact of total net repositioning and other charges by segment. These amounts are excluded from segment profit as described in Note 17 Segment Financial Data: Three Months Ended March 31, 2022 2021 Aerospace $ 21 $ 48 Honeywell Building Technologies 14 5 Performance Materials and Technologies 159 5 Safety and Productivity Solutions 127 37 Corporate and All Other 66 46 $ 387 $ 141 In the three months ended March 31, 2022, the Company recognized gross repositioning charges totaling $147 million, primarily related to closing and relocating the production of certain respiratory manufacturing from a U.S.-based facility to a non-U.S. facility. The repositioning charges include asset impairments of $123 million primarily related to the write-down of certain manufacturing equipment, and exit costs of $17 million primarily for current period costs incurred for previously approved repositioning projects, closure obligations associated with site transitions, and lease obligations for equipment. These charges also include severance costs of $7 million related to workforce reductions of 1,196 manufacturing and administrative positions across all of the Company's segments. Further, during the three months ended March 31, 2022, Selling, general and administrative expenses on the Consolidated Statement of Operations and within Other charges on the table above included $183 million of reserves against outstanding accounts receivable, contract assets, and impairments of other assets due to the suspension of substantially all of the Company's sales, distribution and service activities in Russia and Belarus, sanctions, and deteriorating trade relations in Russia due to the Russia-Ukraine conflict. Based on available information to date, the Company’s estimate of potential future impairments on the Company's businesses in Russia would not be material with respect to the Company's consolidated financial position. In the three months ended March 31, 2021, the Company recognized gross repositioning charges totaling $119 million including severance costs of $28 million related to workforce reductions of 1,021 manufacturing and administrative positions mainly in the Company's Aerospace and Safety and Productivity Solutions segments. The workforce reductions were primarily related to site transitions, mainly in Aerospace, to more cost-effective locations and to the Company's productivity and ongoing functional transformation initiatives. The repositioning charge included asset impairments of $42 million primarily related to the write-down of certain manufacturing and other equipment due to their planned disposition. The repositioning charge included exit costs of $49 million primarily for closure obligations associated with site transitions, lease exit obligations for certain equipment in Corporate and current period exit costs incurred for previously approved repositioning projects. The following table summarizes the status of the Company's total repositioning reserves: Severance Asset Exit Total Balance at December 31, 2021 $ 289 $ — $ 122 $ 411 Charges 7 123 17 147 Usage - cash (48) — (21) (69) Usage - noncash — (123) — (123) Foreign currency translation (1) — — (1) Adjustments (14) — (1) (15) Balance at March 31, 2022 $ 233 $ — $ 117 $ 350

INCOME TAXES

INCOME TAXES	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The effective tax rate was higher than the U.S. federal statutory rate of 21% and increased during 2022 compared to 2021 primarily due to the accrual of reserves against outstanding accounts receivable, contract assets, and impairments of other assets due to the suspension of substantially all of the Company's sales, distribution, and service activities in Russia and Belarus with no corresponding tax benefit, lower tax benefits for employee share-based compensation, and incremental tax reserves and state taxes, partially offset by the favorable resolution of certain foreign tax matters.

INVENTORIES

INVENTORIES	3 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES March 31, 2022 December 31, 2021 Raw materials $ 1,556 $ 1,352 Work in process 958 861 Finished products 2,958 2,925 $ 5,472 $ 5,138

LONG-TERM DEBT AND CREDIT AGREE

LONG-TERM DEBT AND CREDIT AGREEMENTS	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
LONG-TERM DEBT AND CREDIT AGREEMENTS	LONG-TERM DEBT AND CREDIT AGREEMENTS March 31, 2022 December 31, 2021 0.483% notes due 2022 $ 500 $ 500 2.15% notes due 2022 600 600 Floating rate notes due 2022 600 600 1.30% Euro notes due 2023 1,381 1,416 3.35% notes due 2023 300 300 0.00% Euro notes due 2024 552 566 2.30% notes due 2024 750 750 1.35% notes due 2025 1,250 1,250 2.50% notes due 2026 1,500 1,500 1.10% notes due 2027 1,000 1,000 2.25% Euro notes due 2028 829 849 2.70% notes due 2029 750 750 1.95% notes due 2030 1,000 1,000 1.75% notes due 2031 1,500 1,500 0.75% Euro notes due 2032 552 566 5.70% notes due 2036 441 441 5.70% notes due 2037 462 462 5.375% notes due 2041 417 417 3.812% notes due 2047 445 445 2.80% notes due 2050 750 750 Industrial development bond obligations, floating rate maturing at various dates through 2037 22 22 6.625% debentures due 2028 201 201 9.065% debentures due 2033 51 51 Other (including capitalized leases), 7.8% weighted average interest rate maturing at various dates through 2026 197 332 Debt issuance costs (207) (211) 15,843 16,057 Less-current portion (3,207) (1,803) $ 12,636 $ 14,254 On August 16, 2021, the Company issued $1.0 billion 1.10% Senior Notes due 2027 and $1.5 billion 1.75% Senior Notes due 2031 (collectively, the Notes). The Company may redeem the Notes at any time, and from time to time, in whole or in part, at the Company's option at the applicable make-whole redemption price. The Notes are senior unsecured and unsubordinated obligations of the Company and rank equally with each other and with all of the Company's existing and future senior unsecured debt and senior to all of the Company's subordinated debt. The offering provided gross proceeds of $2.5 billion, offset by $18.0 million in discount and closing costs related to the offering. The Company used the proceeds of the offering to redeem at par $2 billion of the $2.5 billion in outstanding principal amount of the Company's callable 0.483% Senior Notes due 2022 and to redeem in full and at par $500 million callable Floating rate Senior Notes due 2022 that the Company issued in August 2020. On March 24, 2022, the Company entered into a $4.0 billion Amended and Restated Five Year Credit Agreement (the 5-Year Credit Agreement) and a $1.5 billion 364-Day Credit Agreement (the 364-Day Credit Agreement). The 5-Year Credit Agreement amended and restated the previously reported $4.0 billion amended and restated five-year credit agreement dated as of March 31, 2021. Commitments under the 5-Year Credit Agreement can be increased pursuant to the terms of the 5-Year Credit Agreement to an aggregate amount not to exceed $4.5 billion. The 364-Day Credit Agreement replaced the $1.5 billion 364-day credit agreement dated as of March 31, 2021, which was terminated in accordance with its terms effective March 24, 2022. Amounts borrowed under the 364-Day Credit Agreement are required to be repaid no later than March 23, 2023, unless (i) Honeywell elects to convert all then outstanding amounts into a term loan, upon which such amounts shall be repaid in full on March 23, 2024, or (ii) the 364-Day Credit Agreement is terminated earlier pursuant to its terms. The 5-Year Credit Agreement and the 364-Day Credit Agreement are maintained for general corporate purposes. As of March 31, 2022, there were no outstanding borrowings under the 5-Year Credit Agreement or the 364-Day Credit Agreement.

LEASES

LEASES	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
LEASES	LEASES The Company's operating and finance lease portfolio is described in Note 10 Leases of Notes to Consolidated Financial Statements in the 2021 Annual Report on Form 10-K. Supplemental cash flow information related to leases was as follows: Three Months Ended March 31, 2022 2021 Net right-of-use assets obtained in exchange for lease obligations: Operating leases $ 47 $ 33 Finance leases 17 3 Supplemental balance sheet information related to leases was as follows: March 31, 2022 December 31, 2021 Operating leases Other assets $ 962 $ 947 Accrued liabilities 206 185 Other liabilities 843 847 Total operating lease liabilities $ 1,049 $ 1,032 Financing leases Property, plant and equipment $ 344 $ 325 Accumulated depreciation (172) (177) Property, plant and equipment - net $ 172 $ 148 Current maturities of long-term debt 66 57 Long-term debt 113 99 Total financing lease liabilities $ 179 $ 156
LEASES	LEASES The Company's operating and finance lease portfolio is described in Note 10 Leases of Notes to Consolidated Financial Statements in the 2021 Annual Report on Form 10-K. Supplemental cash flow information related to leases was as follows: Three Months Ended March 31, 2022 2021 Net right-of-use assets obtained in exchange for lease obligations: Operating leases $ 47 $ 33 Finance leases 17 3 Supplemental balance sheet information related to leases was as follows: March 31, 2022 December 31, 2021 Operating leases Other assets $ 962 $ 947 Accrued liabilities 206 185 Other liabilities 843 847 Total operating lease liabilities $ 1,049 $ 1,032 Financing leases Property, plant and equipment $ 344 $ 325 Accumulated depreciation (172) (177) Property, plant and equipment - net $ 172 $ 148 Current maturities of long-term debt 66 57 Long-term debt 113 99 Total financing lease liabilities $ 179 $ 156

DERIVATIVE INSTRUMENTS AND HEDG

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS	3 Months Ended
	Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS	DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS Honeywell's credit, market, foreign currency, and interest rate risk management policies are described in Note 11 Derivative Instruments and Hedging Transactions of Notes to Consolidated Financial Statements in the Company's 2021 Annual Report on Form 10-K. During March 2022, the Company entered into certain commodity contracts. The Company's risk management policy related to commodity contracts is described in the below section. All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Accrued liabilities or Other liabilities. COMMODITY CONTRACTS RISK MANAGEMENT The Company's operations subject us to risk related to the price volatility of certain commodities. To mitigate the commodity price risk associated with the Company's operations, the Company may enter into commodity derivative instruments. In March 2022, the Company entered into various contracts to mitigate commodity price volatility. The Company elected to apply hedge accounting to these contracts. The following table summarizes the notional amounts and fair values of the Company’s outstanding derivatives by risk category and instrument type within the Consolidated Balance Sheet as of March 31, 2022, and December 31, 2021: Notional Fair Value Asset Fair Value (Liability) March 31, 2022 December 31, 2021 March 31, 2022 December 31, 2021 March 31, 2022 December 31, 2021 Derivatives in Fair Value Hedging Relationships: Interest rate swap agreements $ 3,150 $ 3,150 $ 3 $ 60 $ (80) $ — Derivatives in Cash Flow Hedging Relationships: Foreign currency exchange contracts 3,876 647 13 4 — — Commodity contracts 12 — — — (2) — Derivatives in Net Investment Hedging Relationships: Foreign currency exchange contracts 284 746 93 92 — — Cross currency swap agreements 1,200 1,200 70 39 — — Total Derivatives Designated as Hedging Instruments 8,522 5,743 179 195 (82) — Derivatives Not Designated as Hedging Instruments: Foreign currency exchange contracts 8,944 11,278 286 278 (286) (282) Total Derivatives at Fair Value $ 17,466 $ 17,021 $ 465 $ 473 $ (368) $ (282) In addition to the derivative instruments listed above, certain of the Company's foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was $2,593 million and $4,074 million as of March 31, 2022, and December 31, 2021, respectively. The following table sets forth the amounts recorded on the Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges: Line in the Consolidated Balance Sheet of Hedged Item Carrying Amount of the Hedged Item Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Item March 31, 2022 December 31, 2021 March 31, 2022 December 31, 2021 Long-term debt $ 3,073 $ 3,210 $ (77) $ 60 The following tables summarize the location and impact to the Consolidated Statement of Operations related to derivative instruments: Three Months Ended March 31, 2022 Net Sales Cost of Cost of Selling, general and administrative expenses Other Interest and Other $ 8,376 $ 4,373 $ 1,301 $ 1,431 $ (319) $ 85 Gain or (loss) on cash flow hedges: Foreign currency exchange contracts: Amount reclassified from accumulated other comprehensive income into income 1 1 — 1 — — Gain or (loss) on fair value hedges: Interest rate swap agreements: Hedged items — — — — — 137 Derivatives designated as hedges — — — — — (137) Gain or (loss) on net investment hedges: Foreign Currency Exchange Contracts: Amount excluded from effectiveness testing recognized in earnings using an amortization approach — — — — — 4 Gain or (loss) on derivatives not designated as hedging instruments: Foreign currency exchange contracts — — — — 66 — Three Months Ended March 31, 2021 Net Sales Cost of Cost of Selling, general and administrative expenses Other Interest and Other $ 8,454 $ 4,551 $ 1,158 $ 1,236 $ (442) $ 90 Gain or (loss) on cash flow hedges: Foreign currency exchange contracts: Amount reclassified from accumulated other comprehensive income into income 1 1 — 2 — — Gain or (loss) on fair value hedges: Interest rate swap agreements: Hedged items — — — — — 94 Derivatives designated as hedges — — — — — (94) Gain or (loss) on net investment hedges: Foreign Currency Exchange Contracts: Amount excluded from effectiveness testing recognized in earnings using an amortization approach — — — — — 4 Gain or (loss) on derivatives not designated as hedging instruments: Foreign currency exchange contracts — — — — 60 — The following table summarizes the amounts of gain or (loss) on net investment hedges recognized in Accumulated other comprehensive income (loss): Derivatives Net Investment Hedging Relationships Three Months Ended March 31, 2022 2021 Euro-denominated long-term debt $ 83 $ 150 Euro-denominated commercial paper 17 30 Cross currency swap 17 44 Foreign currency exchange contracts — (2)

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS The accounting guidance for fair value measurements and disclosures establishes a three-level fair value hierarchy: • Level 1 - Inputs are based on quoted prices in active markets for identical assets and liabilities. • Level 2 - Inputs are based on observable inputs other than quoted prices in active markets for identical or similar assets and liabilities. • Level 3 - One or more inputs are unobservable and significant. Financial and nonfinancial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The following table sets forth the Company’s financial assets and liabilities accounted for at fair value on a recurring basis: March 31, 2022 December 31, 2021 Level 1 Level 2 Total Level 1 Level 2 Total Assets: Foreign currency exchange contracts $ — $ 392 $ 392 $ — $ 374 $ 374 Available for sale investments 91 580 671 176 566 742 Interest rate swap agreements — 3 3 — 60 60 Cross currency swap agreements — 70 70 — 39 39 Investments in equity securities 21 30 51 34 23 57 Total assets $ 112 $ 1,075 $ 1,187 $ 210 $ 1,062 $ 1,272 Liabilities: Foreign currency exchange contracts $ — $ 286 $ 286 $ — $ 282 $ 282 Interest rate swap agreements — 80 80 — — — Commodity contracts — 2 2 — — — Total liabilities $ — $ 368 $ 368 $ — $ 282 $ 282 The foreign currency exchange contracts, interest rate swap agreements, cross currency swap agreements and commodity contracts are valued using broker quotations or market transactions in either the listed or over-the-counter markets. As such, these derivative instruments are classified within level 2. The Company also holds investments in commercial paper, certificates of deposits, time deposits, and corporate debt securities that are designated as available for sale, as well as investments in equity securities, which includes holdings of Garrett Motion Inc. (Garrett) Series A Preferred Stock. These investments are valued using published prices based off observable market data. As such, these investments are classified within level 2. The Company holds certain available for sale investments in U.S. government securities, and investments in equity securities, which includes holdings of Garrett common stock. These investments are valued utilizing published prices based on quoted market pricing, which are classified within level 1. The carrying value of cash and cash equivalents, trade accounts and notes receivables, payables, commercial paper, and short-term borrowings approximates fair value. As of March 31, 2022, the Company does not consider any assets or liabilities measured at fair value as level 3. The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value: March 31, 2022 December 31, 2021 Carrying Fair Carrying Fair Assets Short-term investment $ — $ — $ 34 $ 34 Long-term receivables 152 141 170 152 Long-term investment 209 209 366 366 Liabilities Long-term debt and related current maturities $ 15,843 $ 19,303 $ 16,057 $ 17,022 The Company determined the fair value of the long-term receivables by utilizing transactions in the listed markets for identical or similar assets. As such, the fair values of these receivables are considered level 2. On April 30, 2021, the Company received shares of Garrett Series B Preferred Stock in full and final satisfaction of the Garrett Indemnity and Tax Matters Agreement. The fair value of the short-term and long-term investments are based on the present value of the mandatory redemptions as reflected within Garrett's Second and Amended and Restated Series B Preferred Stock (Series B Preferred Stock) Certificate of Designation. The present value reflects amortized cost determined by the present value of the mandatory redemptions discounted at 7.25%, which is the rate reflected in the Second Amended and Restated Series B Preferred Stock Certificate of Designation. The discount rate accretes to interest income over the mandatory redemption period. The investment is designated as held to maturity and was initially recognized at fair value. The fair value of Garrett's Series B Preferred Stock was determined using observable market data and is considered level 2. Fair Value of the Series B Preferred Stock is not impacted by early redemptions until receipt of payment. On February 18, 2022, Garrett early redeemed $197 million of the Series B Preferred Stock, pursuant to the terms and conditions of the Second Amended and Restated Series B Preferred Stock Certificate of Designation. Immediately following the early redemption, the fair value of the Series B Preferred Stock was $207 million.

EARNINGS PER SHARE

EARNINGS PER SHARE	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
EARNINGS PER SHARE	EARNINGS PER SHARE Three Months Ended March 31, Basic 2022 2021 Net income attributable to Honeywell $ 1,134 $ 1,427 Weighted average shares outstanding 684.7 696.2 Earnings per share of common stock - basic $ 1.66 $ 2.05 Three Months Ended March 31, Assuming Dilution 2022 2021 Net income attributable to Honeywell $ 1,134 $ 1,427 Average Shares Weighted average shares outstanding 684.7 696.2 Dilutive securities issuable - stock plans 6.6 8.3 Total weighted average diluted shares outstanding 691.3 704.5 Earnings per share of common stock - assuming dilution $ 1.64 $ 2.03 The diluted earnings per share calculations exclude the effect of stock options when the options’ exercise price exceed the average market price of the common shares during the period. For the three months ended March 31, 2022 and 2021, the weighted average number of stock options excluded from the computations were 3 million and 1 million, respectively. As of March 31, 2022 and 2021, the total shares outstanding were 680.7 million and 694.6 million, respectively, and as of March 31, 2022 and 2021, total shares issued were 957.6 million.

ACCUMULATED OTHER COMPREHENSIVE

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	3 Months Ended
	Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) BY COMPONENT Foreign Pension Changes in Fair Changes in Total Balance at December 31, 2021 $ (2,478) $ (415) $ 1 $ (3) $ (2,895) Other comprehensive income (loss) before reclassifications 129 — (6) 8 131 Amounts reclassified from accumulated other comprehensive income (3) (17) — (3) (23) Net current period other comprehensive income (loss) 126 (17) (6) 5 108 Balance at March 31, 2022 $ (2,352) $ (432) $ (5) $ 2 $ (2,787) Foreign Pension Changes in Fair Changes in Total Balance at December 31, 2020 $ (2,780) $ (601) $ 4 $ — $ (3,377) Other comprehensive income (loss) before reclassifications 216 — (3) 8 221 Amounts reclassified from accumulated other comprehensive income (3) (22) — (3) (28) Net current period other comprehensive income (loss) 213 (22) (3) 5 193 Balance at March 31, 2021 $ (2,567) $ (623) $ 1 $ 5 $ (3,184)

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES ENVIRONMENTAL MATTERS Honeywell's environmental matters are described in Note 19 Commitments and Contingencies of Notes to Consolidated Financial Statements in the Company's 2021 Annual Report on Form 10-K. The following table summarizes information concerning the Company's recorded liabilities for environmental costs: Balance at December 31, 2021 $ 618 Accruals for environmental matters deemed probable and reasonably estimable 49 Environmental liability payments (32) Balance at March 31, 2022 $ 635 Environmental liabilities are included in the following balance sheet accounts: March 31, 2022 December 31, 2021 Accrued liabilities $ 203 $ 225 Other liabilities 432 393 $ 635 $ 618 The Company does not currently possess sufficient information to reasonably estimate the amounts of environmental liabilities to be recorded upon future completion of studies, litigation or settlements, and neither the timing nor the amount of the ultimate costs associated with environmental matters can be determined although they could be material to the Company's consolidated results of operations and operating cash flows in the periods recognized or paid. However, considering the Company's past experience and existing reserves, the Company does not expect that environmental matters will have a material adverse effect on its consolidated financial position. In conjunction with the Resideo Technologies, Inc. (Resideo) spin-off, the Company entered into an indemnification and reimbursement agreement with a Resideo subsidiary, pursuant to which Resideo’s subsidiary has an ongoing obligation to make cash payments to Honeywell in amounts equal to 90% of Honeywell’s annual net spending for environmental matters at certain sites as defined in the agreement. The amount payable to Honeywell in any given year is subject to a cap of $140 million, and the obligation will continue until the earlier of December 31, 2043, or December 31, of the third consecutive year during which the annual payment obligation is less than $25 million. Reimbursements associated with this agreement are collected from Resideo quarterly and were $35 million in the three months ended March 31, 2022, respectively, and offset operating cash outflows incurred by the Company. As the Company incurs costs for environmental matters deemed probable and reasonably estimable related to the sites covered by the indemnification and reimbursement agreement, a corresponding receivable from Resideo for 90% of such costs is also recorded. This receivable amount recorded in the three months ended March 31, 2022, was $35 million. As of March 31, 2022, Other current assets and Other assets included $140 million and $457 million, respectively, for the short-term and long-term portion of the receivable amount due from Resideo under the indemnification and reimbursement agreement. ASBESTOS MATTERS Honeywell is named in asbestos-related personal injury claims related to North American Refractories Company (NARCO), which was sold in 1986, and the Bendix Friction Materials (Bendix) business, which was sold in 2014. The following tables summarize information concerning NARCO and Bendix asbestos-related balances: ASBESTOS-RELATED LIABILITIES Bendix NARCO Total December 31, 2021 $ 1,372 $ 689 $ 2,061 Accrual for update to estimated liability 12 6 18 Change in estimated cost of future claims 8 — 8 Asbestos-related liability payments (41) (11) (52) March 31, 2022 $ 1,351 $ 684 $ 2,035 INSURANCE RECOVERIES FOR ASBESTOS-RELATED LIABILITIES Bendix NARCO Total December 31, 2021 $ 142 $ 221 $ 363 Insurance receipts for asbestos-related liabilities (1) (7) (8) March 31, 2022 $ 141 $ 214 $ 355 NARCO and Bendix asbestos-related balances are included in the following balance sheet accounts: March 31, 2022 December 31, 2021 Other current assets $ 41 $ 41 Insurance recoveries for asbestos-related liabilities 314 322 $ 355 $ 363 Accrued liabilities $ 228 $ 261 Asbestos-related liabilities 1,807 1,800 $ 2,035 $ 2,061 NARCO Products – NARCO manufactured high-grade, heat-resistant, refractory products for various industries. Honeywell’s predecessor, Allied Corporation, owned NARCO from 1979 to 1986. Allied Corporation sold the NARCO business in 1986 and entered into a cross-indemnity agreement which included an obligation to indemnify the purchaser for asbestos claims, arising primarily from alleged occupational exposure to asbestos-containing refractory brick and mortar for high-temperature applications. NARCO ceased manufacturing these products in 1980 and filed for bankruptcy in January 2002, at which point in time all then current and future NARCO asbestos claims were stayed against both NARCO and Honeywell pending the reorganization of NARCO. The Company established its initial liability for NARCO asbestos claims in 2002. NARCO emerged from bankruptcy in April 2013, at which time a federally authorized 524(g) trust was established to evaluate and resolve all existing NARCO asbestos claims (the Trust). Both Honeywell and NARCO are protected by a permanent channeling injunction barring all present and future individual actions in state or federal courts and requiring all asbestos-related claims based on exposure to NARCO asbestos-containing products to be made against the Trust. The NARCO Trust Agreement (TA) and the NARCO Trust Distribution Procedures (TDP) set forth the structure and operating rules of the Trust, and established Honeywell’s evergreen funding obligations. In accordance with the TA, the Trust is eligible to receive cash dividends from Harbison-Walker International Inc. (HWI), the reorganized and renamed entity that emerged from the NARCO bankruptcy. HWI cash dividends are required to be used to pay asbestos-related claims which qualify for payment under the TDP (Annual Contribution Claims) until those funds are exhausted, at which point the Company’s funding obligation, subject to an annual cap of $145 million, is triggered. The Trust received dividend payments from HWI in 2021. The Company is also required to fund amounts owed pursuant to settlement agreements reached during the pendency of the NARCO bankruptcy proceedings that provide for the right to submit claims to the Trust subject to qualification under the terms of the settlement agreements and TDP (Pre-Established Unliquidated Claims), as well as fund the annual operating costs of the Trust. There is no annual funding cap relative to Pre-Established Unliquidated Claims. The operating rules per the TDP define criteria claimants must meet for a claim to be considered valid and paid, which include adequate medical evidence of the claimant’s asbestos-related condition and credible evidence of exposure to a specific NARCO asbestos-containing product. The TDP allows Honeywell to audit claim support documents against these criteria. Once operational in 2014, the Trust began to receive, process and pay claims. The Company identified several issues with the way the Trust was adhering to the TDP in audits subsequent to the Trust becoming operational. The Company consistently raised with the Trust concern that the Trust adopted an improper practice of paying claimants who have not demonstrated the requisite exposure. The Trust refused to alter its practices for payment of claims, and in September 2021, Honeywell filed suit against the Trust in the United States Bankruptcy Court for the Western District of Pennsylvania (Bankruptcy Court) alleging that the Trust has breached its duties in managing the Trust, including breaches of certain provisions of the TA and TDP. Honeywell's lawsuit seeks appropriate relief preventing the Trust from continuing these practices. The Trust also filed suit against Honeywell, alleging Honeywell has breached its obligations under the Trust's governing documents. Honeywell moved to dismiss the Trust’s suit, and on December 15, 2021, the Bankruptcy Court granted Honeywell’s motion to dismiss subject to granting the Trust leave to file an amended complaint. On December 28, 2021, the Trust filed an answer with counterclaims in response to Honeywell’s complaint and in lieu of filing an amended complaint. At this time, the Company cannot predict the outcome of these matters, or the potential impact on the asbestos-related liabilities. Due to the bankruptcy filing in 2002, claimants were not permitted to file additional claims until the Trust became operative in 2014. As a consequence, there was a large backlog of claims filed with the Trust upon it becoming operative in 2014 through December 31, 2017, the date by which these claims had to be filed or else be barred by the expiration of the statute of limitations. Therefore, the claims filing rate did not start to normalize until 2018 and thereafter. As a result, between 2002 and 2018, the Company lacked a history of sufficiently reliable claims data to derive a reasonable estimate of its NARCO asbestos-related liability, and the Company continued to update its original estimate, as appropriate, using all available information. Beginning in 2020, with three years of sufficiently reliable claims data, the Company updated its estimate of the NARCO asbestos-related liability. The estimate for the resolution of asserted Annual Contribution Claims and Pre-Established Unliquidated Claims uses average payment values for the relevant historical period. The estimate for unasserted claims is based on historic and anticipated claims filing experience and payment rates, disease classifications and type of claim, and average payment values by the Trust for the relevant historical period. The Company utilizes an asbestos liability valuation specialist to support the preparation of the NARCO asbestos-related liability estimates during the fourth quarter each year. The Company's estimates, which involve significant management judgment, and consider multiple scenarios, include all years of epidemiological disease projection through 2059. The NARCO asbestos-related liability reflects an estimate for the resolution of Annual Contribution Claims and Pre-Established Unliquidated Claims filed with the Trust, as well as for unasserted Annual Contribution Claims and Pre-Established Unliquidated Claims. The NARCO asbestos-related liability excludes the annual operating expenses of the Trust which are expensed as they are incurred. The Company's NARCO-related insurance receivable reflects coverage which reimburses Honeywell for portions of NARCO-related claims and defense costs. This coverage is provided by a large number of insurance policies written by dozens of insurance companies in both the domestic insurance market and the London excess market. Honeywell's NARCO-related insurance receivable is an estimate of the probable amount of insurance that is recoverable for asbestos claims. The Company's judgments related to the Company's insurance carriers and insurance coverages are reasonable and consistent with Honeywell's historical dealings and Honeywell's knowledge of any pertinent solvency issues surrounding insurers. Bendix Products – Bendix manufactured automotive brake linings that contained chrysotile asbestos in an encapsulated form. Claimants consist largely of individuals who allege exposure to asbestos from brakes from either performing or being in the vicinity of individuals who performed brake replacements. The following tables present information regarding Bendix-related asbestos claims activity: Three Months Ended Years Ended Claims Activity 2022 2021 2020 Claims unresolved at the beginning of period 6,401 6,242 6,480 Claims filed 525 2,611 2,233 Claims resolved (430) (2,452) (2,471) Claims unresolved at the end of period 6,496 6,401 6,242 March 31, December 31, Disease Distribution of Unresolved Claims 2022 2021 2020 Mesothelioma and other cancer claims 3,837 3,760 3,422 Nonmalignant claims 2,659 2,641 2,820 Total claims 6,496 6,401 6,242 Honeywell has experienced average resolution values per claim excluding legal costs as follows: Years Ended December 31, 2021 2020 2019 2018 2017 (in whole dollars) Malignant claims $ 56,000 $ 61,500 $ 50,200 $ 55,300 $ 56,000 Nonmalignant claims $ 400 $ 550 $ 3,900 $ 4,700 $ 2,800 It is not possible to predict whether resolution values for Bendix-related asbestos claims will increase, decrease or stabilize in the future. The Consolidated Financial Statements reflect an estimated liability for resolution of asserted (claims filed as of the financial statement date) and unasserted Bendix-related asbestos claims, which exclude the Company’s ongoing legal fees to defend such asbestos claims which will continue to be expensed as they are incurred. The Company reflects the inclusion of all years of epidemiological disease projection through 2059 when estimating the liability for unasserted Bendix-related asbestos claims. Such liability for unasserted Bendix-related asbestos claims is based on historic and anticipated claims filing experience and dismissal rates, disease classifications, and resolution values in the tort system for the previous five years. The Company valued Bendix asserted and unasserted claims using average resolution values for the previous five years. The Company updates the resolution values used to estimate the cost of Bendix asserted and unasserted claims during the fourth quarter each year. The Company's insurance receivable corresponding to the liability for settlement of asserted and unasserted Bendix asbestos claims reflects coverage which is provided by a large number of insurance policies written by dozens of insurance companies in both the domestic insurance market and the London excess market. Based on the Company's ongoing analysis of the probable insurance recovery, insurance receivables are recorded in the financial statements simultaneous with the recording of the estimated liability for the underlying asbestos claims. This determination is based on the Company's analysis of the underlying insurance policies, historical experience with insurers, ongoing review of the solvency of insurers, judicial determinations relevant to insurance programs, and consideration of the impacts of any settlements reached with the Company's insurers. On October 31, 2018, David Kanefsky (Plaintiff), a Honeywell shareholder, filed a putative class action complaint in the U.S. District Court for the District of New Jersey (the Court) alleging violations of the Securities Exchange Act of 1934 and Rule 10b-5 related to the prior accounting for Bendix asbestos claims. An Amended Complaint was filed on December 30, 2019, and on February 7, 2020, the Company filed a Motion to Dismiss. On May 18, 2020, the Court denied the Motion to Dismiss. On December 7, 2021, the parties filed a Stipulation of Settlement (Settlement Agreement) and Plaintiff filed a motion for preliminary approval of the Settlement Agreement, which includes payment by Honeywell of $10 million to settle the claims in dispute. On January 18, 2022, the Court approved the motion for preliminary approval of the Settlement Agreement. The hearing for final court approval of the Settlement Agreement is May 3, 2022. Honeywell continues to believe the claims lack merit and denies wrongdoing as well as any liability for the claims made against Honeywell in the action. OTHER MATTERS The Company is subject to a number of other lawsuits, investigations and disputes (some of which involve substantial amounts claimed) arising out of the conduct of the Company's business, including matters relating to commercial transactions, government contracts, product liability, prior acquisitions and divestitures, employee benefit plans, intellectual property, and environmental, health and safety matters (including the matter described below). The Company recognizes liabilities for any contingency that is probable of occurrence and reasonably estimable. The Company continually assesses the likelihood of adverse judgments or outcomes in such matters, as well as potential ranges of possible losses (taking into consideration any insurance recoveries), based on a careful analysis of each matter with the assistance of outside legal counsel and, if applicable, other experts. Such matters include: • Petrobras and Unaoil – The Company continues to cooperate with investigations by the U.S. Department of Justice (DOJ), the Securities and Exchange Commission (SEC), and the Brazilian authorities relating to the Company's use of third parties who previously worked for the Company's UOP business in Brazil in relation to Petróleo Brasileiro S.A. (Petrobras) in connection with a project awarded in 2010. The investigations focus on compliance with the U.S. Foreign Corrupt Practices Act and similar Brazilian laws (the UOP Matters), and involve, among other things, document production and interviews with former and current management and employees. The DOJ and the SEC are also examining a matter involving a foreign subsidiary’s prior contract with Unaoil S.A.M. in Algeria executed in 2011. The Company continues to be engaged in discussions with the authorities with respect to a potential comprehensive resolution of these matters. As the discussions are both ongoing and at different stages with regards to each respective authority, there can be no assurance as to whether the Company will reach a resolution with such authorities or as to the potential timing, terms, or collateral consequences of any such resolution. As a result, the Company cannot predict the ultimate outcome of these UOP Matters or the potential impact on the Company. Based on available information to date, the Company estimates that a potential comprehensive resolution of these UOP Matters would result in a probable loss of at least $160 million. During 2021, the Company recorded a charge in this amount in the Company's Consolidated Statement of Operations, and accrued a corresponding liability on the Consolidated Balance Sheet. Amounts payable to authorities pursuant to any potential final comprehensive resolution could differ from the amount recorded in the Company's consolidated financial statements. Based on available information to date, the Company does not expect that any such difference would be material with respect to the Company's consolidated financial position.

PENSION BENEFITS

PENSION BENEFITS	3 Months Ended
	Mar. 31, 2022
Retirement Benefits [Abstract]
PENSION BENEFITS	PENSION BENEFITS Net periodic pension benefit costs for the Company's significant defined benefit plans include the following components: Net Periodic Benefit Cost U.S. Plans Three Months Ended March 31, 2022 2021 Service cost $ 21 $ 26 Interest cost 95 77 Expected return on plan assets (320) (305) Amortization of prior service (credit) (10) (11) $ (214) $ (213) Net Periodic Benefit Cost Non-U.S. Plans Three Months Ended March 31, 2022 2021 Service cost $ 5 $ 7 Interest cost 28 19 Expected return on plan assets (75) (87) $ (42) $ (61)

OTHER (INCOME) EXPENSE

OTHER (INCOME) EXPENSE	3 Months Ended
	Mar. 31, 2022
Other Income and Expenses [Abstract]
OTHER (INCOME) EXPENSE	OTHER (INCOME) EXPENSE Three Months Ended March 31, 2022 2021 Interest income $ (20) $ (19) Pension ongoing income – non-service (285) (310) Other postretirement income – non-service (10) (17) Equity income of affiliated companies (14) (14) (Gain) loss on sale of non-strategic businesses and assets — (90) Foreign exchange (2) 5 Other (net) 12 3 $ (319) $ (442)

SEGMENT FINANCIAL DATA

SEGMENT FINANCIAL DATA	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
SEGMENT FINANCIAL DATA	SEGMENT FINANCIAL DATA Honeywell globally manages its business operations through four reportable operating segments. Segment information is consistent with how management reviews the businesses, makes investing and resource allocation decisions and assesses operating performance. Honeywell’s senior management evaluates segment performance based on segment profit. Each segment’s profit is measured as segment income (loss) before taxes excluding general corporate unallocated expense, interest and other financial charges, stock compensation expense, pension and other postretirement income (expense), repositioning and other charges, and other items within Other (income) expense. Three Months Ended March 31, 2022 2021 Net sales Aerospace Products $ 1,461 $ 1,515 Services 1,288 1,117 Total 2,749 2,632 Honeywell Building Technologies Products 1,082 1,009 Services 347 349 Total 1,429 1,358 Performance Materials and Technologies Products 1,956 1,869 Services 497 477 Total 2,453 2,346 Safety and Productivity Solutions Products 1,633 2,016 Services 111 102 Total 1,744 2,118 Corporate and All Other Services 1 — Total 1 — $ 8,376 $ 8,454 Segment profit Aerospace $ 753 $ 762 Honeywell Building Technologies 336 305 Performance Materials and Technologies 510 434 Safety and Productivity Solutions 253 303 Corporate and All Other (86) (29) Total segment profit 1,766 1,775 Interest and other financial charges (85) (90) Stock compensation expense (a) (60) (77) Pension ongoing income (b) 251 276 Other postretirement income (b) 10 17 Repositioning and other charges (c) (387) (141) Other (d) 10 101 Income before taxes $ 1,505 $ 1,861 (a) Amounts included in Selling, general and administrative expenses. (b) Amounts included in Cost of products and services sold and Selling, general and administrative expenses (service cost component) and Other (income) expense (non-service cost component). (c) Amounts included in Cost of products and services sold, Selling, general and administrative expenses, and Other (income) expense.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Reclassifications	Certain prior year amounts have been reclassified to conform to the current year presentation.
Recent Accounting Pronouncements	The Company considers the applicability and impact of all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB). ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company's Consolidated Financial Statements. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by the transition away from reference rates expected to be discontinued to alternative reference rates. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope , to expand the scope of this guidance to include derivatives. The guidance was effective upon issuance and may be applied prospectively to contract modifications made and hedging relationships entered into on or before December 31, 2022. The Company will apply the guidance to impacted transactions during the transition period. The adoption of this standard does not have a material impact on the Company’s Consolidated Financial Statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805) : Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. This ASU should be applied prospectively to acquisitions occurring on or after the effective date of December 15, 2022, and early adoption is permitted. The Company adopted this guidance on January 1, 2022. The adoption of this standard does not have a material impact on the Company’s Consolidated Financial Statements.
Revenue Recognition and Contracts with Customers	Aerospace – A global supplier of products, software and services for aircrafts that it sells to OEM and other customers in a variety of end markets including: air transport, regional, business and general aviation aircraft, airlines, aircraft operators and defense and space contractors. Aerospace products and services include auxiliary power units, propulsion engines, environmental control systems, integrated avionics, wireless connectivity services, electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, management and technical services, advanced systems and instruments, satellite and space components, aircraft wheels and brakes, repair, and overhaul services and thermal systems. Aerospace also provides spare parts, repair, overhaul and maintenance services (principally to aircraft operators) for the aftermarket. Honeywell Forge solutions are leveraged by the Company's customers as tools to turn data into predictive maintenance and predictive analytics to enable better fleet management and make flight operations more efficient. Honeywell Building Technologies – A global provider of products, software, solutions, and technologies that enable building owners and occupants to ensure their facilities are safe, energy efficient, sustainable, and productive. Honeywell Building Technologies products and services include advanced software applications for building control and optimization; sensors, switches, control systems, and instruments for energy management; access control; video surveillance; fire products; and installation, maintenance and upgrades of systems. Honeywell Forge solutions enable the Company's customers to digitally manage buildings, connecting data from different assets to enable smart maintenance, improve building performance, and even protect from incoming security threats. Performance Materials and Technologies – A global provider in developing and manufacturing high-quality performance chemicals and materials, process technologies, and automation solutions. The segment is comprised of Process Solutions, UOP, and Advanced Materials. Process Solutions provides automation control, instrumentation, advanced software, and related services for the oil and gas, refining, pulp and paper, industrial power generation, chemicals and petrochemicals, biofuels, life sciences, and metals, minerals, and mining industries. Through its smart energy products, Process Solutions enables utilities and distribution companies to deploy advanced capabilities to improve operations, reliability, and environmental sustainability. UOP provides process technology, products, including catalysts and adsorbents, equipment, and consulting services that enable customers to efficiently produce gasoline, diesel, jet fuel, petrochemicals and renewable fuels for the petroleum refining, gas processing, petrochemical, and other industries. Advanced Materials manufactures a wide variety of high-performance products, including materials used to manufacture end products such as bullet-resistant armor, nylon, computer chips, and pharmaceutical packaging, and provides reduced and low global-warming-potential materials based on hydrofluoro-olefin technology. In the industrial environment, Honeywell Forge solutions enable integration and connectivity to provide a holistic view of operations and turn data into clear actions to maximize productivity and efficiency. Honeywell Forge's cybersecurity capabilities help identify risks and act on cyber-related incidents, together enabling improved operations and protecting processes, people and assets. Safety and Productivity Solutions – A global provider of products and software that improve productivity, workplace safety and asset performance to customers around the globe. Safety products include PPE, apparel, gear, and footwear; gas detection technology; and cloud-based notification and emergency messaging. Productivity Solutions products and services include mobile devices and software for computing, data collection, and thermal printing; supply chain and warehouse automation equipment, software and solutions; custom-engineered sensors, switches and controls for sensing and productivity solutions; and software-based data and asset management productivity solutions. Honeywell Forge solutions digitally automate processes to improve efficiency while reducing downtime and safety costs. Corporate and All Other – Corporate and All Other includes revenue from Honeywell's majority-owned investment in Quantinuum. Through Quantinuum, Honeywell provides a wide range of service offerings of fully integrated quantum computing hardware and software solutions. For a summary by disaggregated product and services sales for each segment, refer to Note 17 Segment Financial Data. When contracts are modified to account for changes in contract specifications and requirements, the Company considers whether the modification either creates new or changes the existing enforceable rights and obligations. Contract modifications that are for goods or services that are not distinct from the existing contract, due to the significant integration with the original good or service provided, are accounted for as if they were part of that existing contract. The effect of a contract modification on the transaction price, and the Company's measure of progress for the performance obligation to which it relates, is recognized as an adjustment to revenue (either as an increase in or a reduction of revenue) on a cumulative catch-up basis. When the modifications include additional performance obligations that are distinct and at relative stand-alone selling price, they are accounted for as a new contract and performance obligation, which are recognized prospectively. PERFORMANCE OBLIGATIONS A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is defined as the unit of account. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When the Company's contracts with customers require highly complex integration or manufacturing services that are not separately identifiable from other promises in the contracts and, therefore, not distinct, then the entire contract is accounted for as a single performance obligation. In situations when the Company's contract includes distinct goods or services that are substantially the same and have the same pattern of transfer to the customer over time, they are recognized as a series of distinct goods or services. For any contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation based on the estimated relative standalone selling price of each distinct good or service in the contract. For product sales, each product sold to a customer typically represents a distinct performance obligation. In such cases, the observable standalone sales are used to determine the standalone selling price. Performance obligations are satisfied as of a point in time or over time. Performance obligations are supported by contracts with customers, providing a framework for the nature of the distinct goods, services or bundle of goods and services. The timing of satisfying the performance obligation is typically indicated by the terms of the contract. Performance obligations recognized as of March 31, 2022, will be satisfied over the course of future periods. The Company's disclosure of the timing for satisfying the performance obligation is based on the requirements of contracts with customers. However, from time to time, these contracts may be subject to modifications, impacting the timing of satisfying the performance obligations. Performance obligations expected to be satisfied within one year and greater than one year are 59% and 41%, respectively. The timing of satisfaction of the Company's performance obligations does not significantly vary from the typical timing of payment. Typical payment terms of the Company's fixed-price over time contracts include progress payments based on specified events or milestones, or based on project progress. For some contracts the Company may be entitled to receive an advance payment. The Company applied the practical expedient for certain revenue streams to exclude the value of remaining performance obligations for (i) contracts with an original expected term of one year or less or (ii) contracts for which the Company recognizes revenue in proportion to the amount the Company has the right to invoice for services performed.

REVENUE RECOGNITION AND CONTR_2

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS (Tables)	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	See the following table and related discussions by operating segment for details. Three Months Ended March 31, 2022 2021 Aerospace Commercial Aviation Original Equipment $ 478 $ 431 Commercial Aviation Aftermarket 1,168 910 Defense and Space 1,103 1,291 2,749 2,632 Honeywell Building Technologies Products 879 784 Building Solutions 550 574 1,429 1,358 Performance Materials and Technologies UOP 480 527 Process Solutions 1,152 1,096 Advanced Materials 821 723 2,453 2,346 Safety and Productivity Solutions Safety and Retail 511 743 Productivity Solutions and Services 391 346 Warehouse and Workflow Solutions 599 831 Advanced Sensing Technologies 243 198 1,744 2,118 Corporate and All Other 1 — Net sales $ 8,376 $ 8,454 Three Months Ended March 31, 2022 2021 Products, transferred point in time 59 % 58 % Products, transferred over time 14 18 Net product sales 73 76 Services, transferred point in time 8 7 Services, transferred over time 19 17 Net service sales 27 24 Net sales 100 % 100 %
Contract with Customer Asset and Liability	The following table summarizes the Company's contract assets and liabilities balances: 2022 2021 Contract assets - January 1 $ 2,060 $ 1,618 Contract assets - March 31 2,170 1,789 Change in contract assets - increase (decrease) $ 110 $ 171 Contract liabilities - January 1 $ (4,290) $ (4,033) Contract liabilities - March 31 (4,323) (3,994) Change in contract liabilities - decrease (increase) $ (33) $ 39 Net change $ 77 $ 210
Revenue Remaining Performance Obligation Expected Timing of Satisfaction	The following table outlines the Company's remaining performance obligations disaggregated by segment: March 31, 2022 Aerospace $ 10,211 Honeywell Building Technologies 7,177 Performance Materials and Technologies 7,245 Safety and Productivity Solutions 3,861 Corporate and All Other (1) 1 Total Performance Obligations $ 28,495 (1) The remaining performance obligations within Corporate and All Other relate to the Quantinuum business.

REPOSITIONING AND OTHER CHARG_2

REPOSITIONING AND OTHER CHARGES (Tables)	3 Months Ended
	Mar. 31, 2022
Restructuring and Related Activities [Abstract]
Repositioning and Other Charges	A summary of repositioning and other charges follows: Three Months Ended March 31, 2022 2021 Severance $ 7 $ 28 Asset impairments 123 42 Exit costs 17 49 Reserve adjustments (15) 1 Total net repositioning charge 132 120 Asbestos related litigation charges, net of insurance and reimbursements 46 21 Probable and reasonably estimable environmental liabilities, net of reimbursements 14 5 Other 195 (5) Total net repositioning and other charges $ 387 $ 141
Pretax Distribution of Total Net Repositioning and Other Charges	The following table summarizes the pretax distribution of total net repositioning and other charges by classification: Three Months Ended March 31, 2022 2021 Cost of products and services sold $ 199 $ 98 Selling, general and administrative expenses 188 43 $ 387 $ 141
Pretax Impact of Total Net Repositioning and Other Charges by Segment	The following table summarizes the pretax impact of total net repositioning and other charges by segment. These amounts are excluded from segment profit as described in Note 17 Segment Financial Data: Three Months Ended March 31, 2022 2021 Aerospace $ 21 $ 48 Honeywell Building Technologies 14 5 Performance Materials and Technologies 159 5 Safety and Productivity Solutions 127 37 Corporate and All Other 66 46 $ 387 $ 141
Total Repositioning Reserves	The following table summarizes the status of the Company's total repositioning reserves: Severance Asset Exit Total Balance at December 31, 2021 $ 289 $ — $ 122 $ 411 Charges 7 123 17 147 Usage - cash (48) — (21) (69) Usage - noncash — (123) — (123) Foreign currency translation (1) — — (1) Adjustments (14) — (1) (15) Balance at March 31, 2022 $ 233 $ — $ 117 $ 350

INVENTORIES (Tables)

INVENTORIES (Tables)	3 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
Inventories	March 31, 2022 December 31, 2021 Raw materials $ 1,556 $ 1,352 Work in process 958 861 Finished products 2,958 2,925 $ 5,472 $ 5,138

LONG-TERM DEBT AND CREDIT AGR_2

LONG-TERM DEBT AND CREDIT AGREEMENTS (Tables)	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Long-Term Debt	March 31, 2022 December 31, 2021 0.483% notes due 2022 $ 500 $ 500 2.15% notes due 2022 600 600 Floating rate notes due 2022 600 600 1.30% Euro notes due 2023 1,381 1,416 3.35% notes due 2023 300 300 0.00% Euro notes due 2024 552 566 2.30% notes due 2024 750 750 1.35% notes due 2025 1,250 1,250 2.50% notes due 2026 1,500 1,500 1.10% notes due 2027 1,000 1,000 2.25% Euro notes due 2028 829 849 2.70% notes due 2029 750 750 1.95% notes due 2030 1,000 1,000 1.75% notes due 2031 1,500 1,500 0.75% Euro notes due 2032 552 566 5.70% notes due 2036 441 441 5.70% notes due 2037 462 462 5.375% notes due 2041 417 417 3.812% notes due 2047 445 445 2.80% notes due 2050 750 750 Industrial development bond obligations, floating rate maturing at various dates through 2037 22 22 6.625% debentures due 2028 201 201 9.065% debentures due 2033 51 51 Other (including capitalized leases), 7.8% weighted average interest rate maturing at various dates through 2026 197 332 Debt issuance costs (207) (211) 15,843 16,057 Less-current portion (3,207) (1,803) $ 12,636 $ 14,254

LEASES (Tables)

LEASES (Tables)	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Lease Cost Information	Supplemental cash flow information related to leases was as follows: Three Months Ended March 31, 2022 2021 Net right-of-use assets obtained in exchange for lease obligations: Operating leases $ 47 $ 33 Finance leases 17 3
Supplemental Balance Sheet Information	Supplemental balance sheet information related to leases was as follows: March 31, 2022 December 31, 2021 Operating leases Other assets $ 962 $ 947 Accrued liabilities 206 185 Other liabilities 843 847 Total operating lease liabilities $ 1,049 $ 1,032 Financing leases Property, plant and equipment $ 344 $ 325 Accumulated depreciation (172) (177) Property, plant and equipment - net $ 172 $ 148 Current maturities of long-term debt 66 57 Long-term debt 113 99 Total financing lease liabilities $ 179 $ 156

DERIVATIVE INSTRUMENTS AND HE_2

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS (Tables)	3 Months Ended
	Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The following table summarizes the notional amounts and fair values of the Company’s outstanding derivatives by risk category and instrument type within the Consolidated Balance Sheet as of March 31, 2022, and December 31, 2021: Notional Fair Value Asset Fair Value (Liability) March 31, 2022 December 31, 2021 March 31, 2022 December 31, 2021 March 31, 2022 December 31, 2021 Derivatives in Fair Value Hedging Relationships: Interest rate swap agreements $ 3,150 $ 3,150 $ 3 $ 60 $ (80) $ — Derivatives in Cash Flow Hedging Relationships: Foreign currency exchange contracts 3,876 647 13 4 — — Commodity contracts 12 — — — (2) — Derivatives in Net Investment Hedging Relationships: Foreign currency exchange contracts 284 746 93 92 — — Cross currency swap agreements 1,200 1,200 70 39 — — Total Derivatives Designated as Hedging Instruments 8,522 5,743 179 195 (82) — Derivatives Not Designated as Hedging Instruments: Foreign currency exchange contracts 8,944 11,278 286 278 (286) (282) Total Derivatives at Fair Value $ 17,466 $ 17,021 $ 465 $ 473 $ (368) $ (282)
Schedule of Derivative Instruments	The following table sets forth the amounts recorded on the Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges: Line in the Consolidated Balance Sheet of Hedged Item Carrying Amount of the Hedged Item Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Item March 31, 2022 December 31, 2021 March 31, 2022 December 31, 2021 Long-term debt $ 3,073 $ 3,210 $ (77) $ 60
Derivative Instruments, Gain (Loss)	The following tables summarize the location and impact to the Consolidated Statement of Operations related to derivative instruments: Three Months Ended March 31, 2022 Net Sales Cost of Cost of Selling, general and administrative expenses Other Interest and Other $ 8,376 $ 4,373 $ 1,301 $ 1,431 $ (319) $ 85 Gain or (loss) on cash flow hedges: Foreign currency exchange contracts: Amount reclassified from accumulated other comprehensive income into income 1 1 — 1 — — Gain or (loss) on fair value hedges: Interest rate swap agreements: Hedged items — — — — — 137 Derivatives designated as hedges — — — — — (137) Gain or (loss) on net investment hedges: Foreign Currency Exchange Contracts: Amount excluded from effectiveness testing recognized in earnings using an amortization approach — — — — — 4 Gain or (loss) on derivatives not designated as hedging instruments: Foreign currency exchange contracts — — — — 66 — Three Months Ended March 31, 2021 Net Sales Cost of Cost of Selling, general and administrative expenses Other Interest and Other $ 8,454 $ 4,551 $ 1,158 $ 1,236 $ (442) $ 90 Gain or (loss) on cash flow hedges: Foreign currency exchange contracts: Amount reclassified from accumulated other comprehensive income into income 1 1 — 2 — — Gain or (loss) on fair value hedges: Interest rate swap agreements: Hedged items — — — — — 94 Derivatives designated as hedges — — — — — (94) Gain or (loss) on net investment hedges: Foreign Currency Exchange Contracts: Amount excluded from effectiveness testing recognized in earnings using an amortization approach — — — — — 4 Gain or (loss) on derivatives not designated as hedging instruments: Foreign currency exchange contracts — — — — 60 —
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)	The following table summarizes the amounts of gain or (loss) on net investment hedges recognized in Accumulated other comprehensive income (loss): Derivatives Net Investment Hedging Relationships Three Months Ended March 31, 2022 2021 Euro-denominated long-term debt $ 83 $ 150 Euro-denominated commercial paper 17 30 Cross currency swap 17 44 Foreign currency exchange contracts — (2)

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis	The following table sets forth the Company’s financial assets and liabilities accounted for at fair value on a recurring basis: March 31, 2022 December 31, 2021 Level 1 Level 2 Total Level 1 Level 2 Total Assets: Foreign currency exchange contracts $ — $ 392 $ 392 $ — $ 374 $ 374 Available for sale investments 91 580 671 176 566 742 Interest rate swap agreements — 3 3 — 60 60 Cross currency swap agreements — 70 70 — 39 39 Investments in equity securities 21 30 51 34 23 57 Total assets $ 112 $ 1,075 $ 1,187 $ 210 $ 1,062 $ 1,272 Liabilities: Foreign currency exchange contracts $ — $ 286 $ 286 $ — $ 282 $ 282 Interest rate swap agreements — 80 80 — — — Commodity contracts — 2 2 — — — Total liabilities $ — $ 368 $ 368 $ — $ 282 $ 282
Financial Assets and Liabilities That Were Not Carried at Fair Value	The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value: March 31, 2022 December 31, 2021 Carrying Fair Carrying Fair Assets Short-term investment $ — $ — $ 34 $ 34 Long-term receivables 152 141 170 152 Long-term investment 209 209 366 366 Liabilities Long-term debt and related current maturities $ 15,843 $ 19,303 $ 16,057 $ 17,022

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Earnings Per Share Basic	Three Months Ended March 31, Basic 2022 2021 Net income attributable to Honeywell $ 1,134 $ 1,427 Weighted average shares outstanding 684.7 696.2 Earnings per share of common stock - basic $ 1.66 $ 2.05
Earnings Per Share Diluted	Three Months Ended March 31, Assuming Dilution 2022 2021 Net income attributable to Honeywell $ 1,134 $ 1,427 Average Shares Weighted average shares outstanding 684.7 696.2 Dilutive securities issuable - stock plans 6.6 8.3 Total weighted average diluted shares outstanding 691.3 704.5 Earnings per share of common stock - assuming dilution $ 1.64 $ 2.03

ACCUMULATED OTHER COMPREHENSI_2

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)	3 Months Ended
	Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Changes in Accumulated Other Comprehensive Income by Component	Foreign Pension Changes in Fair Changes in Total Balance at December 31, 2021 $ (2,478) $ (415) $ 1 $ (3) $ (2,895) Other comprehensive income (loss) before reclassifications 129 — (6) 8 131 Amounts reclassified from accumulated other comprehensive income (3) (17) — (3) (23) Net current period other comprehensive income (loss) 126 (17) (6) 5 108 Balance at March 31, 2022 $ (2,352) $ (432) $ (5) $ 2 $ (2,787) Foreign Pension Changes in Fair Changes in Total Balance at December 31, 2020 $ (2,780) $ (601) $ 4 $ — $ (3,377) Other comprehensive income (loss) before reclassifications 216 — (3) 8 221 Amounts reclassified from accumulated other comprehensive income (3) (22) — (3) (28) Net current period other comprehensive income (loss) 213 (22) (3) 5 193 Balance at March 31, 2021 $ (2,567) $ (623) $ 1 $ 5 $ (3,184)

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Loss Contingency	The following table summarizes information concerning the Company's recorded liabilities for environmental costs: Balance at December 31, 2021 $ 618 Accruals for environmental matters deemed probable and reasonably estimable 49 Environmental liability payments (32) Balance at March 31, 2022 $ 635
Environmental Liabilities are Included in the Following Balance Sheet Accounts	Environmental liabilities are included in the following balance sheet accounts: March 31, 2022 December 31, 2021 Accrued liabilities $ 203 $ 225 Other liabilities 432 393 $ 635 $ 618
Asbestos Related Liabilities	Bendix NARCO Total December 31, 2021 $ 1,372 $ 689 $ 2,061 Accrual for update to estimated liability 12 6 18 Change in estimated cost of future claims 8 — 8 Asbestos-related liability payments (41) (11) (52) March 31, 2022 $ 1,351 $ 684 $ 2,035
Insurance Recoveries for Asbestos Related Liabilities	Bendix NARCO Total December 31, 2021 $ 142 $ 221 $ 363 Insurance receipts for asbestos-related liabilities (1) (7) (8) March 31, 2022 $ 141 $ 214 $ 355
NARCO and Bendix Asbestos Related Balances are Included in the Following Balance Sheet Accounts	NARCO and Bendix asbestos-related balances are included in the following balance sheet accounts: March 31, 2022 December 31, 2021 Other current assets $ 41 $ 41 Insurance recoveries for asbestos-related liabilities 314 322 $ 355 $ 363 Accrued liabilities $ 228 $ 261 Asbestos-related liabilities 1,807 1,800 $ 2,035 $ 2,061
Bendix Related Asbestos Claims Activity	The following tables present information regarding Bendix-related asbestos claims activity: Three Months Ended Years Ended Claims Activity 2022 2021 2020 Claims unresolved at the beginning of period 6,401 6,242 6,480 Claims filed 525 2,611 2,233 Claims resolved (430) (2,452) (2,471) Claims unresolved at the end of period 6,496 6,401 6,242
Disease Distribution of Claims	March 31, December 31, Disease Distribution of Unresolved Claims 2022 2021 2020 Mesothelioma and other cancer claims 3,837 3,760 3,422 Nonmalignant claims 2,659 2,641 2,820 Total claims 6,496 6,401 6,242
Average Resolution Values per Asbestos Claim	Honeywell has experienced average resolution values per claim excluding legal costs as follows: Years Ended December 31, 2021 2020 2019 2018 2017 (in whole dollars) Malignant claims $ 56,000 $ 61,500 $ 50,200 $ 55,300 $ 56,000 Nonmalignant claims $ 400 $ 550 $ 3,900 $ 4,700 $ 2,800

PENSION BENEFITS (Tables)

PENSION BENEFITS (Tables)	3 Months Ended
	Mar. 31, 2022
Retirement Benefits [Abstract]
Defined Benefit Plans Disclosure	Net periodic pension benefit costs for the Company's significant defined benefit plans include the following components: Net Periodic Benefit Cost U.S. Plans Three Months Ended March 31, 2022 2021 Service cost $ 21 $ 26 Interest cost 95 77 Expected return on plan assets (320) (305) Amortization of prior service (credit) (10) (11) $ (214) $ (213) Net Periodic Benefit Cost Non-U.S. Plans Three Months Ended March 31, 2022 2021 Service cost $ 5 $ 7 Interest cost 28 19 Expected return on plan assets (75) (87) $ (42) $ (61)

OTHER (INCOME) EXPENSE (Tables)

OTHER (INCOME) EXPENSE (Tables)	3 Months Ended
	Mar. 31, 2022
Other Income and Expenses [Abstract]
Other (income) expense	Three Months Ended March 31, 2022 2021 Interest income $ (20) $ (19) Pension ongoing income – non-service (285) (310) Other postretirement income – non-service (10) (17) Equity income of affiliated companies (14) (14) (Gain) loss on sale of non-strategic businesses and assets — (90) Foreign exchange (2) 5 Other (net) 12 3 $ (319) $ (442)

SEGMENT FINANCIAL DATA (Tables)

SEGMENT FINANCIAL DATA (Tables)	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Segment Financial Data	Three Months Ended March 31, 2022 2021 Net sales Aerospace Products $ 1,461 $ 1,515 Services 1,288 1,117 Total 2,749 2,632 Honeywell Building Technologies Products 1,082 1,009 Services 347 349 Total 1,429 1,358 Performance Materials and Technologies Products 1,956 1,869 Services 497 477 Total 2,453 2,346 Safety and Productivity Solutions Products 1,633 2,016 Services 111 102 Total 1,744 2,118 Corporate and All Other Services 1 — Total 1 — $ 8,376 $ 8,454 Segment profit Aerospace $ 753 $ 762 Honeywell Building Technologies 336 305 Performance Materials and Technologies 510 434 Safety and Productivity Solutions 253 303 Corporate and All Other (86) (29) Total segment profit 1,766 1,775 Interest and other financial charges (85) (90) Stock compensation expense (a) (60) (77) Pension ongoing income (b) 251 276 Other postretirement income (b) 10 17 Repositioning and other charges (c) (387) (141) Other (d) 10 101 Income before taxes $ 1,505 $ 1,861 (a) Amounts included in Selling, general and administrative expenses. (b) Amounts included in Cost of products and services sold and Selling, general and administrative expenses (service cost component) and Other (income) expense (non-service cost component). (c) Amounts included in Cost of products and services sold, Selling, general and administrative expenses, and Other (income) expense.

ACQUISITIONS AND DIVESTITURES (

ACQUISITIONS AND DIVESTITURES (Details) - USD ($) $ in Millions	Jan. 18, 2022	Mar. 31, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill		$ 17,863	$ 17,756
US Digital Design, Inc.
Business Acquisition [Line Items]
Percentage aquired	100.00%
Consideration amount	$ 184
Intangible assets acquired		47
Goodwill		$ 133

REVENUE RECOGNITION AND CONTR_3

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS - Disaggregation (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Disaggregation of Revenue [Line Items]
Net sales	$ 8,376	$ 8,454
Net sales - percentage	100.00%	100.00%
Corporate and All Other
Disaggregation of Revenue [Line Items]
Net sales	$ 1	$ 0
Product
Disaggregation of Revenue [Line Items]
Net sales	$ 6,132	$ 6,409
Net sales - percentage	73.00%	76.00%
Product | Transferred point in time
Disaggregation of Revenue [Line Items]
Net sales - percentage	59.00%	58.00%
Product | Transferred over time
Disaggregation of Revenue [Line Items]
Net sales - percentage	14.00%	18.00%
Service
Disaggregation of Revenue [Line Items]
Net sales	$ 2,244	$ 2,045
Net sales - percentage	27.00%	24.00%
Service | Corporate and All Other
Disaggregation of Revenue [Line Items]
Net sales	$ 1	$ 0
Service | Transferred point in time
Disaggregation of Revenue [Line Items]
Net sales - percentage	8.00%	7.00%
Service | Transferred over time
Disaggregation of Revenue [Line Items]
Net sales - percentage	19.00%	17.00%
Aerospace | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	$ 2,749	$ 2,632
Aerospace | Commercial Aviation Original Equipment | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	478	431
Aerospace | Commercial Aviation Aftermarket | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,168	910
Aerospace | Defense and Space | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,103	1,291
Aerospace | Product | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,461	1,515
Aerospace | Service | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,288	1,117
Honeywell Building Technologies | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,429	1,358
Honeywell Building Technologies | Products | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	879	784
Honeywell Building Technologies | Building Solutions | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	550	574
Honeywell Building Technologies | Product | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,082	1,009
Honeywell Building Technologies | Service | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	347	349
Performance Materials and Technologies | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	2,453	2,346
Performance Materials and Technologies | UOP | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	480	527
Performance Materials and Technologies | Process Solutions | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,152	1,096
Performance Materials and Technologies | Advanced Materials | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	821	723
Performance Materials and Technologies | Product | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,956	1,869
Performance Materials and Technologies | Service | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	497	477
Safety and Productivity Solutions | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,744	2,118
Safety and Productivity Solutions | Safety and Retail | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	511	743
Safety and Productivity Solutions | Productivity Solutions and Services | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	391	346
Safety and Productivity Solutions | Warehouse and Workflow Solutions | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	599	831
Safety and Productivity Solutions | Advanced Sensing Technologies | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	243	198
Safety and Productivity Solutions | Product | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,633	2,016
Safety and Productivity Solutions | Service | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	$ 111	$ 102

REVENUE RECOGNITION AND CONTR_4

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS - Contract Assets and Liabilities (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Contract With Customer, Asset And Liability [Roll Forward]
Contract assets - beginning balance	$ 2,060	$ 1,618
Contract assets - ending balance	2,170	1,789
Change in contract assets - increase (decrease)	110	171
Contract liabilities - beginning balance	(4,290)	(4,033)
Contract liabilities - ending balance	(4,323)	(3,994)
Change in contract liabilities - decrease (increase)	(33)	39
Net change	77	210
Contract liability, revenue recognized	927	$ 1,120
Unbilled balances	$ 2,143		$ 2,035

REVENUE RECOGNITION AND CONTR_5

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS - Performance Obligation (Details) $ in Millions	Mar. 31, 2022USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation, amount	$ 28,495
Corporate and All Other
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation, amount	1
Aerospace | Operating Segments
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation, amount	10,211
Honeywell Building Technologies | Operating Segments
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation, amount	7,177
Performance Materials and Technologies | Operating Segments
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation, amount	7,245
Safety and Productivity Solutions | Operating Segments
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation, amount	$ 3,861
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations, period	1 year
Performance obligation, percentage	59.00%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations, period
Performance obligation, percentage	41.00%

REPOSITIONING AND OTHER CHARG_3

REPOSITIONING AND OTHER CHARGES - Repositioning and Other Charges (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Restructuring Cost and Reserve [Line Items]
Total net repositioning charge	$ 132	$ 120
Asbestos related litigation charges, net of insurance and reimbursements	46	21
Probable and reasonably estimable environmental liabilities, net of reimbursements	14	5
Other	195	(5)
Total net repositioning and other charges	387	141
Severance
Restructuring Cost and Reserve [Line Items]
Total net repositioning charge	7	28
Asset impairments
Restructuring Cost and Reserve [Line Items]
Total net repositioning charge	123	42
Exit costs
Restructuring Cost and Reserve [Line Items]
Total net repositioning charge	17	49
Reserve adjustments
Restructuring Cost and Reserve [Line Items]
Total net repositioning charge	$ (15)	$ 1

REPOSITIONING AND OTHER CHARG_4

REPOSITIONING AND OTHER CHARGES - Pretax Distribution of Total Net Repositioning (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Pretax Distribution Of Total Net Repositioning And Other Charges By Income Statement Classification [Line Items]
Total net repositioning charges	$ 387	$ 141
Cost of products and services sold
Pretax Distribution Of Total Net Repositioning And Other Charges By Income Statement Classification [Line Items]
Total net repositioning charges	199	98
Selling, general and administrative expenses
Pretax Distribution Of Total Net Repositioning And Other Charges By Income Statement Classification [Line Items]
Total net repositioning charges	$ 188	$ 43

REPOSITIONING AND OTHER CHARG_5

REPOSITIONING AND OTHER CHARGES - Pretax Impact of Total net Repositioning and Other Charges by Segment (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	$ 387	$ 141
Corporate and All Other
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	66	46
Aerospace | Operating Segments
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	21	48
Honeywell Building Technologies | Operating Segments
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	14	5
Performance Materials and Technologies | Operating Segments
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	159	5
Safety and Productivity Solutions | Operating Segments
Pretax Impact Of Total Net Repositioning And Other Charges By Segment [Line Items]
Total net repositioning charges	$ 127	$ 37

REPOSITIONING AND OTHER CHARG_6

REPOSITIONING AND OTHER CHARGES - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2022USD ($)employee	Mar. 31, 2021USD ($)employee
Restructuring Cost and Reserve [Line Items]
Charges	$ 147	$ 119
Restructuring costs	$ 132	$ 120
Number of employees severed | employee	1,196	1,021
Reserves against outstanding accounts receivables, contract assets and impairments of other assets	$ 387	$ 141
Selling, general and administrative expenses
Restructuring Cost and Reserve [Line Items]
Reserves against outstanding accounts receivables, contract assets and impairments of other assets	188	43
Russia and Ukraine Conflict | Selling, general and administrative expenses
Restructuring Cost and Reserve [Line Items]
Reserves against outstanding accounts receivables, contract assets and impairments of other assets	183
Severance
Restructuring Cost and Reserve [Line Items]
Charges	7
Restructuring costs	7	28
Asset impairments
Restructuring Cost and Reserve [Line Items]
Charges	123
Restructuring costs	123	42
Exit costs
Restructuring Cost and Reserve [Line Items]
Charges	17
Restructuring costs	17	49
Restructuring costs incurred to date	$ 11	$ 10

REPOSITIONING AND OTHER CHARG_7

REPOSITIONING AND OTHER CHARGES - Repositioning Reserves (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Restructuring Reserve [Roll Forward]
Balance at beginning of period	$ 411
Charges	147	$ 119
Usage - cash	(69)
Usage - noncash	(123)
Foreign currency translation	(1)
Adjustments	(15)
Balance at end of period	350
Severance Costs
Restructuring Reserve [Roll Forward]
Balance at beginning of period	289
Charges	7
Usage - cash	(48)
Usage - noncash	0
Foreign currency translation	(1)
Adjustments	(14)
Balance at end of period	233
Asset impairments
Restructuring Reserve [Roll Forward]
Balance at beginning of period	0
Charges	123
Usage - cash	0
Usage - noncash	(123)
Foreign currency translation	0
Adjustments	0
Balance at end of period	0
Exit costs
Restructuring Reserve [Roll Forward]
Balance at beginning of period	122
Charges	17
Usage - cash	(21)
Usage - noncash	0
Foreign currency translation	0
Adjustments	(1)
Balance at end of period	$ 117

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 1,556	$ 1,352
Work in process	958	861
Finished products	2,958	2,925
Inventories	$ 5,472	$ 5,138

LONG-TERM DEBT AND CREDIT AGR_3

LONG-TERM DEBT AND CREDIT AGREEMENTS - Schedule (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021	Aug. 16, 2021
Debt Instrument [Line Items]
Debt issuance costs	$ (207,000,000)	$ (211,000,000)
Total long-term debt, including current portion	15,843,000,000	16,057,000,000
Less-current portion	(3,207,000,000)	(1,803,000,000)
Noncurrent portion	12,636,000,000	14,254,000,000
0.483% notes due 2022
Debt Instrument [Line Items]
Senior notes	$ 500,000,000	500,000,000	$ 2,500,000,000
Interest rate	0.483%
2.15% notes due 2022
Debt Instrument [Line Items]
Senior notes	$ 600,000,000	600,000,000
Interest rate	2.15%
Floating rate notes due 2022
Debt Instrument [Line Items]
Senior notes	$ 600,000,000	600,000,000
1.30% Euro notes due 2023
Debt Instrument [Line Items]
Senior notes	$ 1,381,000,000	1,416,000,000
Interest rate	1.30%
3.35% notes due 2023
Debt Instrument [Line Items]
Senior notes	$ 300,000,000	300,000,000
Interest rate	3.35%
0.00% Euro notes due 2024
Debt Instrument [Line Items]
Senior notes	$ 552,000,000	566,000,000
Interest rate	0.00%
2.30% notes due 2024
Debt Instrument [Line Items]
Senior notes	$ 750,000,000	750,000,000
Interest rate	2.30%
1.35% notes due 2025
Debt Instrument [Line Items]
Senior notes	$ 1,250,000,000	1,250,000,000
Interest rate	1.35%
2.50% notes due 2026
Debt Instrument [Line Items]
Senior notes	$ 1,500,000,000	1,500,000,000
Interest rate	2.50%
1.10% notes due 2027
Debt Instrument [Line Items]
Senior notes	$ 1,000,000,000	1,000,000,000	1,000,000,000
Interest rate	1.10%
2.25% Euro notes due 2028
Debt Instrument [Line Items]
Senior notes	$ 829,000,000	849,000,000
Interest rate	2.25%
2.70% notes due 2029
Debt Instrument [Line Items]
Senior notes	$ 750,000,000	750,000,000
Interest rate	2.70%
1.95% notes due 2030
Debt Instrument [Line Items]
Senior notes	$ 1,000,000,000	1,000,000,000
Interest rate	1.95%
1.75% notes due 2031
Debt Instrument [Line Items]
Senior notes	$ 1,500,000,000	1,500,000,000	$ 1,500,000,000
Interest rate	1.75%
0.75% Euro notes due 2032
Debt Instrument [Line Items]
Senior notes	$ 552,000,000	566,000,000
Interest rate	0.75%
5.70% notes due 2036
Debt Instrument [Line Items]
Senior notes	$ 441,000,000	441,000,000
Interest rate	5.70%
5.70% notes due 2037
Debt Instrument [Line Items]
Senior notes	$ 462,000,000	462,000,000
Interest rate	5.70%
5.375% notes due 2041
Debt Instrument [Line Items]
Senior notes	$ 417,000,000	417,000,000
Interest rate	5.375%
3.812% notes due 2047
Debt Instrument [Line Items]
Senior notes	$ 445,000,000	445,000,000
Interest rate	3.812%
2.80% notes due 2050
Debt Instrument [Line Items]
Senior notes	$ 750,000,000	750,000,000
Interest rate	2.80%
Industrial development bond obligations, floating rate maturing at various dates through 2037
Debt Instrument [Line Items]
Industrial development bond	$ 22,000,000	22,000,000
6.625% debentures due 2028
Debt Instrument [Line Items]
Debentures	$ 201,000,000	201,000,000
Interest rate	6.625%
9.065% debentures due 2033
Debt Instrument [Line Items]
Debentures	$ 51,000,000	51,000,000
Interest rate	9.065%
Other (including capitalized leases), 7.8% weighted average interest rate maturing at various dates through 2026
Debt Instrument [Line Items]
Other	$ 197,000,000	$ 332,000,000
Weighted average interest rate	7.80%

LONG-TERM DEBT AND CREDIT AGR_4

LONG-TERM DEBT AND CREDIT AGREEMENTS - Narrative (Details) - USD ($)	Mar. 24, 2022	Aug. 16, 2021	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Debt Instrument [Line Items]
Debt issuance costs				$ 207,000,000		$ 211,000,000
Payment of debt				40,000,000	$ 817,000,000
364-Day Credit Agreement | Line of Credit
Debt Instrument [Line Items]
Debt term	364 days
Short-term debt, borrowing capacity	$ 1,500,000,000		$ 1,500,000,000		1,500,000,000
Short-term outstanding borrowings				0
1.10% notes due 2027
Debt Instrument [Line Items]
Senior notes		$ 1,000,000,000		$ 1,000,000,000		1,000,000,000
Interest rate				1.10%
1.75% notes due 2031
Debt Instrument [Line Items]
Senior notes		1,500,000,000		$ 1,500,000,000		1,500,000,000
Interest rate				1.75%
The Notes
Debt Instrument [Line Items]
Gross proceeds		2,500,000,000
Debt issuance costs		18,000,000
0.483% notes due 2022
Debt Instrument [Line Items]
Senior notes		2,500,000,000		$ 500,000,000		500,000,000
Interest rate				0.483%
Payment of debt		2,000,000,000
Floating rate notes due 2022
Debt Instrument [Line Items]
Senior notes				$ 600,000,000		$ 600,000,000
Payment of debt		$ 500,000,000
Line of Credit | 5-Year Credit Agreement
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 4,000,000,000		$ 4,000,000,000		$ 4,000,000,000
Debt term	5 years		5 years
Borrowing capacity upon certain terms	$ 4,500,000,000
Long-term outstanding borrowings				$ 0

LEASES - Supplemental Cash Flow

LEASES - Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Net right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 47	$ 33
Finance leases	$ 17	$ 3

LEASES - Supplemental Balance S

LEASES - Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Operating leases
Other assets	$ 962	$ 947
Accrued liabilities	206	185
Other liabilities	843	847
Total operating lease liabilities	1,049	1,032
Financing leases
Property, plant and equipment	344	325
Accumulated depreciation	(172)	(177)
Property, plant and equipment - net	172	148
Current maturities of long-term debt	66	57
Long-term debt	113	99
Total financing lease liabilities	$ 179	$ 156
Operating lease, right-of-use asset, statement of financial position	Other assets	Other assets
Operating lease, liability, current, statement of financial position	Accrued Liabilities, Current	Accrued Liabilities, Current
Operating lease, liability, noncurrent, statement of financial position	Other liabilities	Other liabilities
Finance lease, right-of-use asset, statement of financial position	Property, plant and equipment - net	Property, plant and equipment - net
Finance lease, liability, current, statement of financial position	Long-term Debt and Lease Obligation, Current	Long-term Debt and Lease Obligation, Current
Finance lease, liability, noncurrent, statement of financial position	Noncurrent portion	Noncurrent portion

DERIVATIVE INSTRUMENTS AND HE_3

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS - Notional and Fair Value of Outstanding Derivatives (Details) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Derivative [Line Items]
Notional	$ 17,466	$ 17,021
Fair Value Asset	465	473
Fair Value (Liability)	(368)	(282)
Foreign currency exchange contracts
Derivative [Line Items]
Amount of hedged item	2,593	4,074
Derivatives in Fair Value Hedging Relationships:
Derivative [Line Items]
Notional	8,522	5,743
Fair Value Asset	179	195
Fair Value (Liability)	(82)	0
Derivatives in Fair Value Hedging Relationships: | Fair Value Hedging | Interest rate swap agreements
Derivative [Line Items]
Notional	3,150	3,150
Fair Value Asset	3	60
Fair Value (Liability)	(80)	0
Derivatives in Fair Value Hedging Relationships: | Cash Flow Hedging | Foreign currency exchange contracts
Derivative [Line Items]
Notional	3,876	647
Fair Value Asset	13	4
Fair Value (Liability)	0	0
Derivatives in Fair Value Hedging Relationships: | Cash Flow Hedging | Commodity contracts
Derivative [Line Items]
Notional	12	0
Fair Value Asset	0	0
Fair Value (Liability)	(2)	0
Derivatives in Fair Value Hedging Relationships: | Net Investment Hedging | Foreign currency exchange contracts
Derivative [Line Items]
Notional	284	746
Fair Value Asset	93	92
Fair Value (Liability)	0	0
Derivatives in Fair Value Hedging Relationships: | Net Investment Hedging | Cross currency swap agreements
Derivative [Line Items]
Notional	1,200	1,200
Fair Value Asset	70	39
Fair Value (Liability)	0	0
Derivatives Not Designated as Hedging Instruments: | Foreign currency exchange contracts
Derivative [Line Items]
Notional	8,944	11,278
Fair Value Asset	286	278
Fair Value (Liability)	$ (286)	$ (282)

DERIVATIVE INSTRUMENTS AND HE_4

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS - Cumulative Basis Adjustments for Fair Value Hedges (Details) - Long-term debt - Derivatives in Fair Value Hedging Relationships: - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Carrying Amount of the Hedged Item	$ 3,073	$ 3,210
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Item	$ (77)	$ 60

DERIVATIVE INSTRUMENTS AND HE_5

DERIVATIVE INSTRUMENTS AND HEDGING TRANSACTIONS - Location and Impact to Consolidated Statement of Operations Related to Derivative Instruments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Net Sales	$ 8,376	$ 8,454
Costs	5,674	5,709
Selling, general and administrative expenses	1,431	1,236
Other (income) expense	(319)	(442)
Interest and Other Financial Charges	85	90
Foreign currency exchange contracts | Net Sales
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain or (loss) on derivatives not designated as hedging instruments	0	0
Foreign currency exchange contracts | Selling, general and administrative expenses
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain or (loss) on derivatives not designated as hedging instruments	0	0
Foreign currency exchange contracts | Other (Income) Expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain or (loss) on derivatives not designated as hedging instruments	66	60
Foreign currency exchange contracts | Interest and Other Financial Charges
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain or (loss) on derivatives not designated as hedging instruments	0	0
Derivatives in Fair Value Hedging Relationships: | Foreign currency exchange contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain or (loss) on net investment hedges recognized in accumulated other comprehensive income (loss)	0	(2)
Derivatives in Fair Value Hedging Relationships: | Gain or (loss) on cash flow hedges | Foreign currency exchange contracts | Net Sales
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount reclassified from accumulated other comprehensive income into income	1	1
Derivatives in Fair Value Hedging Relationships: | Gain or (loss) on cash flow hedges | Foreign currency exchange contracts | Selling, general and administrative expenses
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount reclassified from accumulated other comprehensive income into income	1	2
Derivatives in Fair Value Hedging Relationships: | Gain or (loss) on cash flow hedges | Foreign currency exchange contracts | Other (Income) Expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount reclassified from accumulated other comprehensive income into income	0	0
Derivatives in Fair Value Hedging Relationships: | Gain or (loss) on cash flow hedges | Foreign currency exchange contracts | Interest and Other Financial Charges
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount reclassified from accumulated other comprehensive income into income	0	0
Derivatives in Fair Value Hedging Relationships: | Gain or (loss) on fair value hedges | Interest rate swap agreements | Net Sales
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged items	0	0
Derivatives designated as hedges	0	0
Derivatives in Fair Value Hedging Relationships: | Gain or (loss) on fair value hedges | Interest rate swap agreements | Selling, general and administrative expenses
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged items	0	0
Derivatives designated as hedges	0	0
Derivatives in Fair Value Hedging Relationships: | Gain or (loss) on fair value hedges | Interest rate swap agreements | Other (Income) Expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged items	0	0
Derivatives designated as hedges	0	0
Derivatives in Fair Value Hedging Relationships: | Gain or (loss) on fair value hedges | Interest rate swap agreements | Interest and Other Financial Charges
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged items	137	94
Derivatives designated as hedges	(137)	(94)
Derivatives in Fair Value Hedging Relationships: | Net Investment Hedging | Foreign currency exchange contracts | Net Sales
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	0	0
Derivatives in Fair Value Hedging Relationships: | Net Investment Hedging | Foreign currency exchange contracts | Selling, general and administrative expenses
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	0	0
Derivatives in Fair Value Hedging Relationships: | Net Investment Hedging | Foreign currency exchange contracts | Other (Income) Expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	0	0
Derivatives in Fair Value Hedging Relationships: | Net Investment Hedging | Foreign currency exchange contracts | Interest and Other Financial Charges
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	4	4
Derivatives in Fair Value Hedging Relationships: | Euro denominated long-term debt
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain or (loss) on net investment hedges recognized in accumulated other comprehensive income (loss)	83	150
Derivatives in Fair Value Hedging Relationships: | Net Investment Euro Denominated Commercial Paper
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain or (loss) on net investment hedges recognized in accumulated other comprehensive income (loss)	17	30
Derivatives in Fair Value Hedging Relationships: | Net Investment Cross Currency Swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain or (loss) on net investment hedges recognized in accumulated other comprehensive income (loss)	17	44
Product
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Net Sales	6,132	6,409
Costs	4,373	4,551
Product | Foreign currency exchange contracts | Cost of products and services sold
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain or (loss) on derivatives not designated as hedging instruments	0	0
Product | Derivatives in Fair Value Hedging Relationships: | Gain or (loss) on cash flow hedges | Foreign currency exchange contracts | Cost of products and services sold
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount reclassified from accumulated other comprehensive income into income	1	1
Product | Derivatives in Fair Value Hedging Relationships: | Gain or (loss) on fair value hedges | Interest rate swap agreements | Cost of products and services sold
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged items	0	0
Derivatives designated as hedges	0	0
Product | Derivatives in Fair Value Hedging Relationships: | Net Investment Hedging | Foreign currency exchange contracts | Cost of products and services sold
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	0	0
Service
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Net Sales	2,244	2,045
Costs	1,301	1,158
Service | Foreign currency exchange contracts | Cost of products and services sold
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain or (loss) on derivatives not designated as hedging instruments	0	0
Service | Derivatives in Fair Value Hedging Relationships: | Gain or (loss) on cash flow hedges | Foreign currency exchange contracts | Cost of products and services sold
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount reclassified from accumulated other comprehensive income into income	0	0
Service | Derivatives in Fair Value Hedging Relationships: | Gain or (loss) on fair value hedges | Interest rate swap agreements | Cost of products and services sold
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedged items	0	0
Derivatives designated as hedges	0	0
Service | Derivatives in Fair Value Hedging Relationships: | Net Investment Hedging | Foreign currency exchange contracts | Cost of products and services sold
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount excluded from effectiveness testing recognized in earnings using an amortization approach	$ 0	$ 0

FAIR VALUE MEASUREMENTS - Asset

FAIR VALUE MEASUREMENTS - Assets and Liabilities Accounted for at Fair Value (Details) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Assets:
Fair value asset	$ 465	$ 473
Liabilities:
Fair value liability	368	282
Fair Value Measurements Recurring
Assets:
Total assets	1,187	1,272
Liabilities:
Total liabilities	368	282
Fair Value Measurements Recurring | Level 1
Assets:
Total assets	112	210
Liabilities:
Total liabilities	0	0
Fair Value Measurements Recurring | Level 2
Assets:
Total assets	1,075	1,062
Liabilities:
Total liabilities	368	282
Fair Value Measurements Recurring | Investments in equity securities
Assets:
Investments in equity securities	51	57
Fair Value Measurements Recurring | Investments in equity securities | Level 1
Assets:
Investments in equity securities	21	34
Fair Value Measurements Recurring | Investments in equity securities | Level 2
Assets:
Investments in equity securities	30	23
Foreign currency exchange contracts | Fair Value Measurements Recurring
Assets:
Fair value asset	392	374
Liabilities:
Fair value liability	286	282
Foreign currency exchange contracts | Fair Value Measurements Recurring | Level 1
Assets:
Fair value asset	0	0
Liabilities:
Fair value liability	0	0
Foreign currency exchange contracts | Fair Value Measurements Recurring | Level 2
Assets:
Fair value asset	392	374
Liabilities:
Fair value liability	286	282
Available for sale investments | Fair Value Measurements Recurring
Assets:
Available for sale investments	671	742
Available for sale investments | Fair Value Measurements Recurring | Level 1
Assets:
Available for sale investments	91	176
Available for sale investments | Fair Value Measurements Recurring | Level 2
Assets:
Available for sale investments	580	566
Interest rate swap agreements | Fair Value Measurements Recurring
Assets:
Fair value asset	3	60
Liabilities:
Fair value liability	80	0
Interest rate swap agreements | Fair Value Measurements Recurring | Level 1
Assets:
Fair value asset	0	0
Liabilities:
Fair value liability	0	0
Interest rate swap agreements | Fair Value Measurements Recurring | Level 2
Assets:
Fair value asset	3	60
Liabilities:
Fair value liability	80	0
Cross currency swap agreements | Fair Value Measurements Recurring
Assets:
Fair value asset	70	39
Liabilities:
Fair value liability	2
Cross currency swap agreements | Fair Value Measurements Recurring | Level 1
Assets:
Fair value asset	0	0
Cross currency swap agreements | Fair Value Measurements Recurring | Level 2
Assets:
Fair value asset	70	39
Liabilities:
Fair value liability	2
Commodity contracts | Fair Value Measurements Recurring
Liabilities:
Fair value liability		0
Commodity contracts | Fair Value Measurements Recurring | Level 1
Liabilities:
Fair value liability	$ 0	0
Commodity contracts | Fair Value Measurements Recurring | Level 2
Liabilities:
Fair value liability		$ 0

FAIR VALUE MEASUREMENTS - Finan

FAIR VALUE MEASUREMENTS - Financial Assets and Liabilities Not Carried at Fair Value (Details) - Level 2 - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Carrying Value
Assets:
Short-term investment	$ 0	$ 34
Long-term receivables	152	170
Long-term investment	209	366
Liabilities:
Long-term debt and related current maturities	15,843	16,057
Fair Value
Assets:
Short-term investment	0	34
Long-term receivables	141	152
Long-term investment	209	366
Liabilities:
Long-term debt and related current maturities	$ 19,303	$ 17,022

FAIR VALUE MEASUREMENTS - Narra

FAIR VALUE MEASUREMENTS - Narrative (Details) - Series B Preferred Stock $ in Millions	Feb. 19, 2022USD ($)	Feb. 18, 2022USD ($)	Apr. 30, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mandatory redemption discount rate			0.0725
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments in equity securities	$ 207	$ 197

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Basic
Net income attributable to Honeywell	$ 1,134	$ 1,427
Weighted average shares outstanding (in shares)	684.7	696.2
Earnings per share of common stock - basic (in dollars per share)	$ 1.66	$ 2.05
Assuming Dilution
Net income attributable to Honeywell	$ 1,134	$ 1,427
Average Shares
Weighted average shares outstanding (in shares)	684.7	696.2
Dilutive securities issuable - stock plans (in shares)	6.6	8.3
Total weighted average shares outstanding (in shares)	691.3	704.5
Earnings per share of common stock - assuming dilution (in dollars per share)	$ 1.64	$ 2.03
Stock options excluded from diluted computations (in shares)	3	1
Total shareowners' equity (in shares)	680.7	694.6
Shares issued (in shares)	957.6	957.6

ACCUMULATED OTHER COMPREHENSI_3

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period	$ 19,242
Other comprehensive income (loss) before reclassifications	131	$ 221
Amounts reclassified from accumulated other comprehensive income	(23)	(28)
Net current period other comprehensive income (loss)	108	193
Balance at end of period	19,051	18,252
Total
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period	(2,895)	(3,377)
Balance at end of period	(2,787)	(3,184)
Foreign Exchange Translation Adjustment
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period	(2,478)	(2,780)
Other comprehensive income (loss) before reclassifications	129	216
Amounts reclassified from accumulated other comprehensive income	(3)	(3)
Net current period other comprehensive income (loss)	126	213
Balance at end of period	(2,352)	(2,567)
Pension and Other Postretirement Benefits Adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period	(415)	(601)
Other comprehensive income (loss) before reclassifications	0	0
Amounts reclassified from accumulated other comprehensive income	(17)	(22)
Net current period other comprehensive income (loss)	(17)	(22)
Balance at end of period	(432)	(623)
Changes in Fair Value of Available for Sale Investments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period	1	4
Other comprehensive income (loss) before reclassifications	(6)	(3)
Amounts reclassified from accumulated other comprehensive income	0	0
Net current period other comprehensive income (loss)	(6)	(3)
Balance at end of period	(5)	1
Changes in Fair Value of Cash Flow Hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Balance at beginning of period	(3)	0
Other comprehensive income (loss) before reclassifications	8	8
Amounts reclassified from accumulated other comprehensive income	(3)	(3)
Net current period other comprehensive income (loss)	5	5
Balance at end of period	$ 2	$ 5

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Environmental Matters (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Accrual for Environmental Loss Contingencies [Roll Forward]
Beginning of period	$ 618
Accruals for environmental matters deemed probable and reasonably estimable	49
Environmental liability payments	(32)
End of period	635
Loss Contingency, Classification of Accrual [Abstract]
Accrued liabilities	203	$ 225
Other liabilities	432	393
Total environmental liabilities	$ 635	$ 618
Environmental Liabilities | Resideo
Loss Contingency, Classification of Accrual [Abstract]
Cash payments of annual environmental spending percentage	90.00%
Indemnification and reimbursement agreement annual cap	$ 140
Indemnification and reimbursement agreement minimum amount	25
Reimbursements from indemnification and reimbursement agreement	$ 35
Receivable as a percentage of environmental costs incurred	90.00%
Reimbursement receivable indemnification and reimbursement agreement	$ 35
Other current assets, reimbursement agreement	140
Other assets, reimbursement agreement	$ 457

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES - Asbestos-Related Liabilities (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Asbestos Related Liabilities Insurance Recoveries [Roll Forward]
Insurance recoveries for asbestos related liabilities	$ 314	$ 322
Asbestos-related liabilities	1,807	1,800
Total
Loss Contingency Accrual [Roll Forward]
Asbestos related liabilities, beginning of period	2,061
Accrual for update to estimated liability	18
Change in estimated cost of future claims	8
Asbestos-related liability payments	(52)
Asbestos related liabilities, end of period	2,035
Asbestos Related Liabilities Insurance Recoveries [Roll Forward]
Insurance recoveries, beginning of period	363
Insurance receipts for asbestos-related liabilities	(8)
Insurance recoveries, end of period	355
Other current assets	41	41
Insurance recoveries for asbestos related liabilities	314	322
Total assets	355	363
Accrued liabilities	228	261
Asbestos-related liabilities	1,807	1,800
Total liabilities	2,035	2,061
Bendix
Loss Contingency Accrual [Roll Forward]
Asbestos related liabilities, beginning of period	1,372
Accrual for update to estimated liability	12
Change in estimated cost of future claims	8
Asbestos-related liability payments	(41)
Asbestos related liabilities, end of period	1,351
Asbestos Related Liabilities Insurance Recoveries [Roll Forward]
Insurance recoveries, beginning of period	142
Insurance receipts for asbestos-related liabilities	(1)
Insurance recoveries, end of period	141
Total assets	141	142
Total liabilities	1,351	1,372
NARCO
Loss Contingency Accrual [Roll Forward]
Asbestos related liabilities, beginning of period	689
Accrual for update to estimated liability	6
Change in estimated cost of future claims	0
Asbestos-related liability payments	(11)
Asbestos related liabilities, end of period	684
Asbestos Related Liabilities Insurance Recoveries [Roll Forward]
Insurance recoveries, beginning of period	221
Insurance receipts for asbestos-related liabilities	(7)
Insurance recoveries, end of period	214
Total assets	214	221
Total liabilities	684	$ 689
Annual trust cap	$ 145

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES - Bendix-Related Asbestos Claims Activity (Details) - Bendix - claim	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Loss Contingency Claims [Roll Forward]
Claims unresolved at the beginning of period	6,401	6,242	6,480
Claims filed	525	2,611	2,233
Claims resolved	(430)	(2,452)	(2,471)
Claims unresolved at the end of period	6,496	6,401	6,242

COMMITMENTS AND CONTINGENCIES_4

COMMITMENTS AND CONTINGENCIES - Disease Distribution of Unresolved Claims (Details) - Bendix - claim	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loss Contingency Disease Distribution Of Unresolved Claims [Line Items]
Mesothelioma and other cancer claims	3,837	3,760	3,422
Nonmalignant claims	2,659	2,641	2,820
Total claims	6,496	6,401	6,242	6,480

COMMITMENTS AND CONTINGENCIES_5

COMMITMENTS AND CONTINGENCIES - Resolution Values Per Claim Excluding Legal Costs (Details) - Bendix - $ / claim	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Resolution Values Per Claim [Line Items]
Malignant claims (in dollars per claim)	56,000	61,500	50,200	55,300	56,000
Nonmalignant claims (in dollars per claim)	400	550	3,900	4,700	2,800

COMMITMENTS AND CONTINGENCIES_6

COMMITMENTS AND CONTINGENCIES - Narrative (Details) $ in Millions	Dec. 07, 2021USD ($)
Settlement Agreement | Bendix
Loss Contingency, Narco and Bendix Asbestos Related Balances by Balance Sheet Caption [Line Items]
Accrued liabilities	$ 10

COMMITMENTS AND CONTINGENCIES_7

COMMITMENTS AND CONTINGENCIES - Other Matters (Details) $ in Millions	3 Months Ended
	Mar. 31, 2022USD ($)
Petrobras
Other Matters [Line Items]
Expense related to UOP Matters	$ 160

PENSION BENEFITS (Details)

PENSION BENEFITS (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 21	$ 26
Interest cost	95	77
Expected return on plan assets	(320)	(305)
Amortization of prior service (credit)	(10)	(11)
Net periodic benefit (income)	(214)	(213)
Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	5	7
Interest cost	28	19
Expected return on plan assets	(75)	(87)
Net periodic benefit (income)	$ (42)	$ (61)

OTHER (INCOME) EXPENSE (Details

OTHER (INCOME) EXPENSE (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Other Income and Expenses [Line Items]
Interest income	$ (20)	$ (19)
Equity income of affiliated companies	(14)	(14)
(Gain) loss on sale of non-strategic businesses and assets	0	(90)
Foreign exchange	(2)	5
Other (net)	12	3
Total	(319)	(442)
Pension Plan
Other Income and Expenses [Line Items]
Ongoing income - non-service	(285)	(310)
Other Postretirement Benefits Plan
Other Income and Expenses [Line Items]
Ongoing income - non-service	$ (10)	$ (17)

SEGMENT FINANCIAL DATA (Details

SEGMENT FINANCIAL DATA (Details) $ in Millions	3 Months Ended
	Mar. 31, 2022USD ($)segment	Mar. 31, 2021USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | segment	4
Net sales	$ 8,376	$ 8,454
Total segment profit	1,766	1,775
Interest and other financial charges	(85)	(90)
Repositioning and other charges	(387)	(141)
Income before taxes	1,505	1,861
Product
Segment Reporting Information [Line Items]
Net sales	6,132	6,409
Service
Segment Reporting Information [Line Items]
Net sales	2,244	2,045
Corporate and All Other
Segment Reporting Information [Line Items]
Net sales	1	0
Total segment profit	(86)	(29)
Repositioning and other charges	(66)	(46)
Corporate and All Other | Service
Segment Reporting Information [Line Items]
Net sales	1	0
Segment Reconciling Items
Segment Reporting Information [Line Items]
Interest and other financial charges	(85)	(90)
Stock compensation expense	(60)	(77)
Repositioning and other charges	(387)	(141)
Other	10	101
Income before taxes	1,505	1,861
Segment Reconciling Items | Pension Plan
Segment Reporting Information [Line Items]
Pension ongoing income	251	276
Segment Reconciling Items | Other Postretirement Benefits Plan
Segment Reporting Information [Line Items]
Pension ongoing income	10	17
Aerospace | Operating Segments
Segment Reporting Information [Line Items]
Net sales	2,749	2,632
Total segment profit	753	762
Repositioning and other charges	(21)	(48)
Aerospace | Operating Segments | Product
Segment Reporting Information [Line Items]
Net sales	1,461	1,515
Aerospace | Operating Segments | Service
Segment Reporting Information [Line Items]
Net sales	1,288	1,117
Honeywell Building Technologies | Operating Segments
Segment Reporting Information [Line Items]
Net sales	1,429	1,358
Total segment profit	336	305
Repositioning and other charges	(14)	(5)
Honeywell Building Technologies | Operating Segments | Product
Segment Reporting Information [Line Items]
Net sales	1,082	1,009
Honeywell Building Technologies | Operating Segments | Service
Segment Reporting Information [Line Items]
Net sales	347	349
Performance Materials and Technologies | Operating Segments
Segment Reporting Information [Line Items]
Net sales	2,453	2,346
Total segment profit	510	434
Repositioning and other charges	(159)	(5)
Performance Materials and Technologies | Operating Segments | Product
Segment Reporting Information [Line Items]
Net sales	1,956	1,869
Performance Materials and Technologies | Operating Segments | Service
Segment Reporting Information [Line Items]
Net sales	497	477
Safety and Productivity Solutions | Operating Segments
Segment Reporting Information [Line Items]
Net sales	1,744	2,118
Total segment profit	253	303
Repositioning and other charges	(127)	(37)
Safety and Productivity Solutions | Operating Segments | Product
Segment Reporting Information [Line Items]
Net sales	1,633	2,016
Safety and Productivity Solutions | Operating Segments | Service
Segment Reporting Information [Line Items]
Net sales	$ 111	$ 102